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Abstract  
This dissertation thesis summarizes results of experiments that have been carried 
out during my PhD studies related to the new mass spectrometric methods for trace 
gas analysis of human breath.  
The thesis is divided into the theoretical and experimental part. The chapter at the 
beginning of this dissertation summarizes the current research in the area of breath 
analysis. It is describing the common breath metabolites, benefits and challenges of 
the method for therapeutic monitoring and clinical diagnosis and current applications. 
The next chapter of the theoretical introduction describes the techniques suitable for 
this area of research, with a special emphasis on mass-spectrometric techniques (in 
particular the selected ion flow tube mass spectrometry, SIFT-MS, method that allows 
accurate quantification of trace gases and vapours in humid air/human breath). All 
these parts are elaborated via the scientific literature review.  
The following chapters are then directly related to my own research and describes 
the conducted experiment, including the results obtained. This experimental part 
“Results and Discussion” is divided to the individual subsections, which are conceived 
as the commentaries to the enclosed research papers published in peer reviewed 
journals. The first is the detailed step by step overview of the kinetics of ion molecule 
reactions (the basis of SIFT-MS) including the determination of rate constants and 
product branching ratios for several ion-molecule reactions of H3O+, NO+ and O2+• 
reagent ions with carboxylic acids and possible Inflammatory Bowel Disease, IBD, 
biomarkers. The latter subsections are focused on three-body association reactions 
related to experiments, where the samples are influenced by the presence of water 
vapour (case of breath analysis), and on optimization of SIFT-MS kinetic library for 
accurate quantifications by this method. The last two sections finally concern the 
application of SIFT-MS for the breath analysis and describe not only results gathered 
in the area of IBD, but also challenges, which are connected with the off-line analysis 
and utilisation of Nalophan sampling bags, that have been encountered during my 
research -  mainly the problematic of impurities released from the Nalophan sampling 
bags (off line analysis), that could significantly involve the SIFT-MS breath analysis, 
where low-level substances are determined. 
  
   
 
Abstrakt  
Tato disertační práce shrnuje výsledky experimentů, na kterých jsem pracovala 
během svého postgraduálního studia zaměřeného na nové metody hmotnostní 
spektrometrie pro stopovou analýzu látek v lidském dechu.  
Disertační práce je rozdělena na teoretickou a experimentální část. Úvodní 
kapitola shrnuje současný výzkum v oblasti analýzy dechu, přičemž popisuje 
metabolity běžně obsažené v dechu, benefity a podněty této metody pro terapeutické 
monitorování, klinickou diagnózu a též současné oblasti aplikace. Další kapitola 
teoretické části popisuje techniky vhodné pro tuto oblast výzkumu, se zvláštním 
důrazem na hmotnostně spektrometrické techniky (zejména pak hmotnostní 
spektrometrii v proudové trubici s vybranými ionty, SIFT-MS, metodu, jež umožňuje 
přesnou kvantifikaci  stopových plynů a par ve vlhkém vzduchu/lidském dechu). Obě 
kapitoly jsou zpracovány formou rešerše. 
Navazující kapitoly se pak přímo týkají mého vlastního výzkumu a popisují 
provedené experimenty i dosažené výsledky. Experimentální část „Výsledky a 
diskuze“ je rozdělena do několika podkapitol, jež jsou koncipovány jako komentáře 
již publikovaných výsledků v impaktovaných časopisech. První podkapitola se 
detailně zabývá iontovou chemií (základ metody SIFT-MS), včetně stanovení poměrů 
větvení a rychlostních konstant reakcí reakčních iontů s vybranými karboxylovými 
kyselinami a možnými biomarkery zánětlivých onemocnění střev, IBD. Další sekce se 
pak věnují třístranným asociačním reakcím u reakcí, kde hraje duležitou roli 
přítomnost vodní páry ve vzorku (právě případ analýzy dechu) a optimalizací SIFT-
MS kinetické knihovny pro přesnou kvantifikaci pomocí této metody. Poslední dvě 
sekce se již věnují aplikaci SIFT-MS pro analýzu dechu a popisují nejen výsledky 
získané v oblasti IBD, ale taktéž problémy, na které jsme během mého výzkumu 
narazili - zejména problematiku nečistot uvolňovaných z Nalophanových sáčků (off-
line analýza), jež mohou významně ovlivnit analýzu dechu pomocí SIFT-MS, kde jsou 
stanovovány látky o velmi nízké koncentraci.  
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1 Aims 
The aim of my PhD research project as formulated at the onset of my 
postgraduate study was: 
 
“To develop new reaction schemes and methodologies in selected ion flow tube mass 
spectrometry, SIFT-MS, based on chemical ionization of volatile substances present in 
the air during a well-defined reaction time using selective ion reagents H3O+, NO+ and 
O2+. This work will include study of reactions of kinetics of ion molecule reactions be the 
use this method in interdisciplinary research, particularly in breath analysis for clinical 
diagnosis and monitoring of therapy. The research will be complemented by the 
development of new physical and chemical extraction methods for pre-concentration of 
trace substances for GC/MS analysis.” 
 
This dissertation shows that I have reached this aim and obtained some interesting and 
original results during the experimental work directed towards this goal. 
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2 Introduction 
As a species, humans require air to survive, a need we share with most other 
members of the Kingdom Animalia. Just as the composition of the inhaled air can provide 
much information about the surrounding environment, the constitution of an exhaled 
breath can have a highly informative value about a particular individual. Such information 
can be than very important for many different applications, namely therapeutic 
monitoring and clinical diagnosis, where breath analysis could nicely supplement the 
standard methods such as blood and urine analysis. 
Human breath is a very complex matrix of volatile organic compounds (VOCs), 
non-volatile organic compounds (aerosol particles), and inorganic compounds. It is 
considered, that human breath contains as many as 300 and even 3500 constituents, most 
of which are present in trace amounts. The typical composition [1] is: unmodified 
(inhaled) nitrogen (somewhat less than 74% by volume if water vapour is included, 79% 
of permanent gases) [2], oxygen (reduced from 21% inhaled to about 13.6-16.0% 
exhaled), water vapour (saturated at 37°C about 6%), carbon dioxide (about 5%, formed 
by respiration and commonly expressed as end-tidal CO2 measured in the traditional units 
of mm Hg, i.e Torr, in the range from 28 to 38) [3] and argon (1%). Along with these 
major and significantly represented substances, the exhaled breath contains also several 
parts per million by volume (ppmv) of methane, hydrogen and carbon monoxide, about 1 
ppmv of ammonia, less than 1 ppmv of acetone, methanol, ethanol and other volatile 
organic compounds, VOCs. The final composition is, however, very variable and depends 
on the inhaled air quality (it is expected that most of these compounds are of exogenous 
origin) and endogenous biological process. The human breath is therefore absolutely 
unique, characteristic and VOCs contained therein carry information concerning the 
biochemical status of an individual [4]. It is also very important to mention, that whereas 
the large number of volatile compounds appear even in the breath of healthy individuals, 
other compounds appear in the breath of diseased ones and certain of normally-occurring 
compounds have been shown to be elevated or decreased in specific diseases [5]. A 
typical example can be elevated concentrations of acetone in breath of patients suffering 
with diabetes [6,7] (which can be seriously, even dominantly influenced by diet – the 
trend common for many different metabolites), added ammonia in renal disease 
(potentially usable in therapeutic monitoring of dialysis) [8-10], nitric oxide in asthma 
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[11, 12] or small hydrocarbons, ethane and pentane, in oxidative stress (the fact, that was 
discussed in numerous studies and in some cases also unproved) [13-15]. 
The monitoring of such differences and in general, the concentration of individual 
VOCs, became the subject of a new scientific discipline, Breath analysis. Breath analysis 
is described as the non-invasive method for gathering the data about the clinical state of 
investigated individuals. 
The area of modern breath testing commenced in 1971, when Nobel Prize winner 
Linus Pauling and co-workers demonstrated that human breath is a complex gas, 
containing well over 200 different VOCs in picomolar concentrations that can be 
separated by gas-liquid partition chromatography [16].  However, physicians are utilising 
a method of breath analysis, in the form of odour sensing, in their profession since the 
days of Hippocrates [17].  
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2.1 Breath analysis of VOCs for therapeutic monitoring and clinical 
diagnosis 
Breath tests, besides a few exceptions, have not been integrated routinely in 
clinical practice. The complex mechanism underlying pulmonary gas exchange makes 
breath analysis a challenging subject and there are still many issues, which have to be 
considered and solved. The examples could be sampling and collection methods, or 
interpretation of results, which can be sometimes ambiguous. Any analytical methods 
used in breath analysis have to cope with different issues. 
  
Figure 2.1. Lungs and airways.  (https://webstockreview.net/explore/lungs-clipart-breathing-rate/) 
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Gas exchange [18] during respiration occurs primarily through diffusion.  It takes 
place between the air within the alveoli and the pulmonary capillaries.  Nowadays, it is 
known that exhaled breath concentrations of VOCs may be even under resting conditions 
significantly influenced by specific physiological parameters such as cardiac output 
(blood pressure, heartbeat rate) and breathing patterns (alveolar ventilation), depending 
on the physico-chemical properties of the compound under study [19]. Understanding the 
influence of these factors is an essential requisite not only for the development of a 
reliable methodology (achieving accurate sample collection, selection of the suitable 
analytical method), but especially for correct deduction of the corresponding blood 
concentration levels.  
Breath gas concentration can be related to blood concentrations via mathematical 
modelling. The simplest model relating breath gas concentration to blood concentrations 
was developed by Farhi (1) [20]: 
𝐶𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 = 𝐶𝐴 =
𝐶𝑉
λ𝑏:𝑎𝑖𝑟 +
𝑉𝐴
𝑄𝐶
 (1) 
 
Here, 𝐶𝐴 denotes the alveolar concentration which is assumed to be equal to the 
measured concentration. It expresses the fact that the concentration of an inert gas in the 
alveolar air depends on the mixed venous concentration, 𝐶𝑉, the substance-specific 
blood:air partition coefficient,  λ𝑏:𝑎𝑖𝑟, describing diffusion equilibrium between capillaries 
and alveoli  and ventilation-perfusion ratio, 
𝑉𝐴
𝑄𝐶
. Ventilation-perfusion ratio ensures that 
the ideal amount blood and gas is received by the alveoli for efficient gas exchange. It 
depends on the alveolar ventilation, 𝑉𝐴, controlling the transport of the VOC through the 
respiratory track, and cardiac output,  𝑄𝐶, controlling the rate at which the VOC is 
delivered to the lungs. Blood:air partition coefficient, λ𝑏:𝑎𝑖𝑟, is strongly dependent on 
temperature ranging from 23 °C in the mouth to 37 °C in the alveoli, affecting soluble gas 
exchange [21]. Unfortunately, this model fails when two prototypical substances like 
acetone (partition coefficient λ𝑏:𝑎𝑖𝑟=340) or isoprene (partition coefficient λ𝑏:𝑎𝑖𝑟= 0.75) 
are measured. 
For low blood soluble gases (λ𝑏:𝑎𝑖𝑟 ≤ 10) [21] the measured concentration is 
dependent on the rates at which blood is pumped through the lungs and ventilation, 
specifically the ventilation-perfusion ratio, where 𝐶𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 = 𝐶𝐴, meaning that low 
blood soluble VOCs must exchange completely in the alveoli.  
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Soluble VOCs (λ𝑏:𝑎𝑖𝑟 > 10) [21] tend to be less affected by changes in ventilation 
and perfusion, however, hydrophilic exhaled trace gases, such as acetone, interact with 
the water-like mucus membrane lining the conductive airways. The exhaled breath 
concentrations of these volatiles appear to dilute on their way up from the deeper 
respiratory track to the airway opening (dilution effect), consequently for these highly 
soluble volatiles the concentration measured in exhaled breath is different from the 
alveolar air concentration, 𝐶𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑 ≠ 𝐶𝐴. There is also evidence that, with highly 
soluble volatile compounds, gas exchange occurs in the airways rather than alveoli [22]. 
There was also a lot of investigation assessing the concentration profiles during 
exercise [19,23-26]. Recently, the influence of exercise on mouth-exhaled and nose-
exhaled breath was further investigated [25]. Smith and co-workers reported significant 
increase of isoprene breath concentrations which are in agreement with previous findings 
[26]. 
Based on the above mentioned facts, it was clear that more refined models are 
necessary to achieve better compliance between VOC breath concentrations and 
corresponding blood concentration levels. An isoprene gas-exchange model (2) was 
developed and showed a good fit to the breath isoprene concentrations measured during 
exercise. Dependency of heartbeat rate and breath rate for isoprene breath concentrations 
have been assessed, where isoprene levels were measured during exercise [19,24]. 
Isoprene concentrations showed a dramatic increase within the initials seconds of exercise 
[19,24], followed by a decline when heartbeat rate reached the maximum value and 
respiration rate increased, and lastly at the end of the exercise isoprene concentrations 
reached similar concentrations seen at the beginning. This means that the degree of blood-
to-air partitioning of isoprene is very sensitive to heart rate. Such measurements 
demonstrate a relationship between breath rate volume, 𝑉𝑏𝑟, heartbeat volume,  𝐻𝐵𝑉, 
Henry’s law constant, 𝐻, and temperature, 𝑇, seen in equation below: 
 
𝐶𝐴0 = 𝐶𝑉0  𝑒𝑥𝑝 (−
1
𝐻𝑅𝑇
 
𝑉𝑏𝑟
𝐻𝐵𝑉
)  (2)  
 
For volatiles such as isoprene, with low solubility in blood and high volatility 
(Henry’s law constant extremely low) a concentration gradient within the lungs is created 
and governed by the velocity of the bloodstream pumped through the lungs (proportional 
to heartbeat frequency) and the breathing rate. Namely, with increases in both heart rate 
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and breathing rate, more efficient partitioning of isoprene to breath air is restored. This 
means that isoprene evaporates efficiently through the transport via the bloodstream to 
the lungs, hence, 𝐶𝐴0 ≠ 𝐶𝑉0, meaning that isoprene venous blood concentration entering 
the lungs, 𝐶𝑉0, is different from isoprene arterial blood concentration leaving the lungs, 
𝐶𝐴0. 
Moreover, measurements taken during sleep showed enhanced blood isoprene 
concentration due to lower heartbeat rate achieved during the night [24]. 
All the above mentioned problems and a lack of normalization and standardization 
are causing a huge variations between results of different studies. Nevertheless in the last 
few years, there is a significant progress in this field and introducing breath analysis into 
clinical practice will be challenge of today and tomorrow. 
 
2.1.1 Common breath metabolites and their physiological 
concentrations 
As was already mentioned above, the VOCs presented in the breath of people can 
be divided to exogenous, originating from current or previous environmental exposures, 
and endogenous, arisen by internal metabolic (anabolic and catabolic) production. 
Exogenous VOCs penetrating the body as a result of environmental exposure can 
be used to quantify a body burden. The example can be the halogenated organic 
compounds, which are analysed for environmental or expositional issues. Also breath 
tests are often based on the ingestion of isotopically labelled precursors, producing 
isotopically labelled carbon dioxide and potentially many other metabolites.  
Endogenous VOCs are released within the human organism as a result of normal 
metabolic activity or due to pathological disorders (see the scheme in Figure 2.2). They 
can be produced at various organs and places in the body, enter the blood stream and are 
eventually metabolized or excreted via exhalation, skin emission, urine, etc. Also the 
production of VOCs by bacteria (oral cavity, gut) is possible. The origins of certain VOCs 
in breath presumed to be endogenous have been proposed to be useful as preclinical 
biomarkers of various undiagnosed diseases including lung cancer, breast cancer, and 
cardio-pulmonary disease. Identification and quantification of potential disease 
biomarkers can be seen as the driving force for the analysis of exhaled breath. Moreover, 
future applications for medical diagnosis and therapy control with dynamic assessments 
of normal physiological function or pharmacodynamics are intended. Nevertheless, in 
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order to develop a diagnostic breath test, ready to be used in clinical practice, it is 
necessary to unravel the baseline physiological concentrations of volatiles present in 
human breath, and their relationship with age, gender, ethnicity, and metabolic changes 
in the body. Such an effort can be seen in many previous studies and projects, some of 
which are mentioned below. 
 
 
Figure 2.2. A scheme of various origins of VOCs in exhaled breath. 
 
Concentrations of common breath metabolites, ammonia, acetone, isoprene, 
ethanol and acetaldehyde have been measured in the selected ion flow tube - mass 
spectrometry (SIFT-MS) in the breath of five healthy volunteers over a period of 30 days 
by Diskin and co-workers [27]. The mean concentrations were calculated, and meaningful 
distributions obtained for ammonia, acetone, isoprene, and ethanol [27,28]. 
Subsequently, the longitudinal SIFT-MS study of common breath metabolites, 
ammonia, acetone, methanol, ethanol, propanol, acetaldehyde and isoprene in the breath 
of 30 healthy subjects over a six-month period has been performed by Turner and co-
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workers [29-32].The study assessed the biological variability and the concentration 
distributions for above mentioned metabolites have been determined on-line in single 
breath exhalations and showed to be a log normal distribution for these metabolites. 
Ammonia was shown to be a major breath metabolite with a median of 833 parts per 
billion by volume (ppbv), followed by acetone (477 ppbv), methanol (461 ppbv), ethanol 
(112 ppbv), isoprene (106 ppbv), propanol (18 ppbv), and acetaldehyde (22 ppbv).  
It has been proved that most of the ammonia observed in mouth-exhaled breath 
has its origin in the oral cavity [33]. Ammonia is also produced systemically, it appears 
in the body as a breakdown product of proteins, a contribution originated from the 
bacterial degradation of protein in the intestine [30]. The metabolic pathway is starting in 
the liver, where the ammonia is converted into urea, which is then eliminated in urine. 
Some of the ammonia is expelled from the breath and some is emitted by the skin [34]. 
The metabolic pathways of acetone are well established. The decarboxylation of 
acetoacetate and the dehydrogenation of isopropanol are the main two sources of acetone 
[35]. Acetone concentrations are elevated in ketosis states including diabetes, the disease 
dominated by two metabolic changes: rise of blood sugar concentration and intensive 
lipolysis [35]. However, acetone was not marked as unique biomarker of diabetes. 
The metabolites belonging to the group of alcohols, methanol and ethanol, may 
arise as anaerobic fermentation products by gut bacteria [36]. This production way is than 
common for all alcohols in the series from methanol to heptanol. Methanol is contained 
in some foods, such as apples and drinks, which, when ingested, increases the methanol 
in the circulation and, hence, in the exhaled breath [36]. Methanol is used industrially as 
a solvent, pesticide, and alternative fuel source. It also occurs naturally in animals and 
plants. Methanol can be absorbed into the body by inhalation, ingestion, skin contact, or 
eye contact. Methanol does not appear to be generated in the mouth and concentrations 
detected in breath are of systemic origin. Most breath ethanol, however, appears to be due 
to mouth fermentation of sugars (unless the subject has been consuming alcoholic drinks) 
[37].  
When we will focus on 2-propanol, we can see that it is a product of the enzyme-
mediated reduction of acetone. Bacteria present in the gut produce several alcohols, 
including the structural isomers isopropanol or 2-propanol and it is this isomer that largely 
exists in the human body [38]. Nevertheless, it is still present in lower concentrations than 
ammonia or other above mentioned VOCs.  
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The biochemical origin of isoprene in human breath is not entirely clear. However, 
it is considered to be a by-product of cholesterol synthesis [39]. Abnormal breath isoprene 
concentrations are related to end-stage renal failure and increases in isoprene 
concentrations have been associated with oxidative stress. However, this assumption has 
not been proved by the work of Lirk and co-workers [40]. As was already mentioned, 
isoprene concentrations are also very variable based on the physical activity (linked to 
local variations of gas exchange in peripheral tissues) [26].  
Acetaldehyde concentrations result from endogenous ethanol metabolism [5]. As 
a consequence, acetaldehyde concentrations in breath are invariably lower than the 
corresponding ethanol concentrations. In healthy individuals, it is rapidly cleared by 
conversion into acetic acid or acetate ions and thus it is present at low concentrations in 
the body. However, these concentrations in breath may not be obvious because 
acetaldehyde can also be produced from cellular activity involving sugars.  
 
2.1.2 Influence of demography (age, gender and diet) 
The wide variation of concentrations of volatile metabolites in human breath can 
be influenced also by many external factors, for example diet and natural intra-individual 
biological and diurnal variability. Therefore the relationship between baseline 
concentrations of common breath VOCs and some demography parameters as age, 
gender, ethnicity and diet has been investigated in many studies. 
Age and gender are important factors to be taken into account in breath analysis. 
Taucher and co-workers recognised that isoprene concentrations in children’s exhaled 
breath are significantly lower than in adults [41,42]. VOCs and particularly isoprene on 
the breath of 126 volunteers have been measured also by Lechner and co-workers, 
reporting an increase in isoprene concentration of exhaled air of male subjects [43]. Both 
studies have been conducted by using proton-transfer-reaction mass spectrometry (PTR-
MS). Also the SIFT-MS studies of age influence on VOCs presence in breath have been 
conducted [38,42,44]. The exhaled breath of several volunteers within the age range 4–
83 years was investigated by Španěl and co-workers, whereas a trend of increasing breath 
ammonia concentration with age has been revealed in this study [44]. Smith and co-
workers also reported apparent elevation of breath isoprene concentrations during 
adolescence, probably due to the onset of puberty, as stated by the authors [42].   
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Another interesting topic involving concentration of VOCs is the ovarian cycle 
and ovulation phase. During analysis of the headspace of urine from a number of female 
volunteers, Smith and co-workers observed acetone and ammonia concentrations 
occasionally higher than the normal. The urine samples were collected before any food 
intake. Such findings suggested that it may be caused by metabolic changes occurring 
during ovulation and related to menstrual cycle length [45,46]. 
There is an influence of food intake and starvation on the concentrations of breath 
metabolites [47] and many studies have been focused on this topic in the past. One of 
them quantified breath metabolites ammonia, methanol, ethanol, propanol, formaldehyde, 
acetaldehyde, isoprene, and acetone by SIFT-MS for a group of five volunteers, before 
and after ingesting 75 g of glucose in the fasting state [34]. Also a study of six healthy 
volunteers following the ingestion of a liquid protein meal [48] and subsequently of a 
liquid carbohydrate meal [49] was carried out to investigate the influence by food intake. 
Alveolar breath concentrations of ammonia, acetone, ethanol, and isoprene were taken 
from single exhalations in the morning following overnight fasting and then for several 
hours after ingestion of the meals. Prior to feeding, the acetone concentrations were 
relatively high and the corresponding ammonia concentrations were relatively low in the 
breath of all six volunteers. Following feeding, the acetone concentrations all decreased 
as the body was nourished. Initially, the ammonia concentrations all reduced towards a 
minimum value (near to 200 ppbv) approximately 30 min after feeding by both the protein 
and the carbohydrate meals and then began to increase in the breath of all six study 
participants. For the (nitrogen containing) protein meal the ammonia increased to values 
obviously greater than their respective initial values, whereas for the carbohydrate meal 
it asymptotically approached the initial values prior feeding. It has been hypothesized by 
the authors, that the initial dip in the ammonia concentrations was the result of an increase 
in portal blood flow as the stomach was loaded with the meal [48,49]. The hypothesis 
above was supported also by an experiment, when the ethanol (three different quantities, 
namely 7.5 ml after fasting, 17 ml after fasting and 2.5 ml immediately after a lunch meal) 
was administered to volunteers in 500 ml of tap water (a volume chosen to mimic the 
large volumes of protein and carbohydrate liquid meals that were used in previous 
experiments. At blood/body water concentrations greater than 0.1 gL−1 it is known that 
ethanol exhibits saturation kinetics, i.e. the rate of elimination is constant regardless of 
concentration [50]). The similar decrease in the breath ammonia was observed within this 
study [37]. There were unexpected increases in the breath ethanol concentrations 
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following the ingestion of both the protein and carbohydrate meals, which were traced to 
the presence of ethanol evidences in the liquid meals. The studies of ethanol metabolism 
were reported by Winkler and co-workers [51]. Metabolic degradation of ethanol was 
tracked by the ingestion of isotope-labelled ethanol using real-time breath gas analysis 
with PTR-MS. The findings indicated that, in part, ethanol was metabolized to acetone 
and isoprene, as deuterated acetone and isoprene were observed in the mass spectra. 
However, the signal of the deuterium-labelled acetaldehyde was not observed, suggesting 
that this product did not enter the blood stream but was rapidly further metabolized. There 
is a lot of foods, such as garlic, onion, mint, banana and coffee, which are known to emit 
volatiles at trace concentrations [52,53]. Therefore, for the breath analysis, it is always 
necessary to take the influence of food into consideration before evaluation of the 
gathered results. 
 
 
Figure 2.3. The complex interactions between diet and expired breath metabolites. (Reproduced from 
Ajibola et al., Journal of Nutritional Science, 2013 [140]). In general are volatile metabolites in the breath 
derived from several sources: environmental inspired air, from cells, including microorganisms that are 
located throughout the oral/nasal cavities and the pulmonary system, the upper and lower gastrointestinal 
tracts and from general human metabolism. 
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2.1.3 Influence of external volatile compounds  
It has been shown that the composition of exhaled breath is considerably 
influenced by exposure to pollution and indoor-air contaminants, for example, smoking-
enhanced acetonitrile concentrations were found in the breath and urine of smokers [54-
57]. The danger of smoking, and to a less extent passive smoking, have been well 
documented and publicized in the past and in addition to the already mentioned 
acetonitrile, compounds like 2,5-dimethylfuran, benzene, toluene, styrene, ethane, 
pentane, hydrogen cyanide (HCN) and carbon monoxide (CO) have been identified as 
characteristic in smokers and passive smokers’ breath [58-62]. Acetonitrile is a compound 
presented in the exhaled breath of smokers at measurable concentrations even several 
days after smoking. After cessation, it takes nearly a week until the concentrations 
decrease to that of non-smokers [54].  Based on above mentioned fact, this cyanide can 
be used as good indicator of whether a given subject is a smoker or not. Increased 
concentrations of exhaled ethane and pentane are probably caused by high concentrations 
of hydrocarbons in cigarette smoke, as well as oxidative damage caused by smoking [60]. 
Measuring carbon monoxide in exhaled breath is also a well-established method used to 
differentiate between smokers and non-smokers [62]. As a constituent of cigarette smoke, 
CO enters the blood circulation during smoking and forms carboxyhemoglobin (COHb). 
The elimination of CO is primarily by respiration, thus, there is a strong correlation 
between CO in breath and COHb [62].  In addition to the above mentioned compounds, 
also concentrations of isoprene, acetone, ammonia and ethanol have been investigated. 
Significant increase (70% in mean) has been observed in case of isoprene. The mean 
increase in acetone concentrations was found to be 22%, in contrast, for ethanol was 
observed mean decrease of 28% [63].   
Aside from smoking, there are other ways of VOCs entering the body. Breath 
contains a diverse range of VOCs that can be taken up by the body through inhalation or 
skin, and, depending on distribution kinetics, may be present in exhaled breath for 
different periods after exposure. For instance, limonene was found in cosmetics, perfumes 
and cleaning products and is emitted by wooden furniture and floorings. It is known to be 
soluble in blood and adipose tissue and, therefore, has the potential to be taken up by the 
body during inhalation [64]. Limonene can be not only inhaled, but also easily ingested. 
This compound occurs in the greatest abundance in citrus fruits, large variety of other 
fruit and vegetables and it is a common additive in commercial food and drinks. There is 
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also a number of studies, which are focusing on exposure of workers to different volatile 
compounds. This area has and continues to receive considerable attention, as it is an 
important area of public concern with serious health implications. The examples could be 
the SIFT-MS studies carried out in collaboration with experienced health and safety 
scientists following breath from a healthy individual who had been exposed for several 
hours to a controlled atmosphere of perchloroethylene (C2Cl4)[65], exposure of healthy 
volunteers to controlled amounts of xylene and trimethylbenzene isomers [66], or intake 
of  anaesthetic gases, halothane, isoﬂurane, and sevoﬂurane, by operating staff [67].  
 
2.2 Sampling and analysis 
The analytical techniques that are available these days for breath analysis can be 
easily divided on those for real time measurements of concentrations of volatile 
metabolites in exhaled breath, i.e. SIFT-MS, PTR-MS, ion mobility spectrometry and 
laser-based spectroscopy [68-78,26,23,47], and the off-line techniques. With regard to 
drawbacks of on-line techniques (high instrumentation costs, a somewhat less certain 
identification of compounds, lack of control over the sampling time), the off-line 
techniques are still the most utilised methods. The off-line exhaled breath analysis is than 
typically carried out by collecting a sample in a suitable container or trap, concentrating 
the analytes of interest by different pre-concentration method (e.g., solid phase 
microextraction (SPME), sorbent trapping, or needle traps (NTD)), and analysing it by 
thermal desorption gas chromatography coupled to mass spectrometry. To wit, gas 
chromatography-mass spectrometry (GC-MS) remains the gold standard for the analysis 
of breath constituents [79-85,5]. For the breath analysis is desirable also monitoring over 
the time, because of biological variability among subjects (an issue in breath sampling). 
This approach than serves as a form of self-control [86]. In order to perform breath 
sampling it is necessary to consider the diffusion of volatile organic compounds from 
blood to alveolar air, which depends on their physicochemical properties, such as, 
polarity, solubility in fat, Henry partition constant, and volatility [28]. 
Concerning the quality of analysis (especially off-line) the sampling and sample 
stability are the most critical steps in the entire analytical procedure. In fact, preservation 
of the sample integrity during sampling and sample storage is probably one of the most 
demanding challenges in analytical chemistry. Different phenomena accompanying these 
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phases of analysis like interaction with the sampling container (adsorption/desorption 
processes and release from the container material itself ), permeation through the 
container walls (loss of sample components and contamination of sample by external 
pollutants), as well as chemical reactions facilitated by high humidity and highly reactive 
species can irreversibly modify the original sample composition, consequently cause the  
alteration of the final results of analysis and lead to erroneous conclusions [87]. This is 
particularly true in the case of exhaled breath analysis. Ultra-low concentrations of 
volatile organic breath constituents (from ppbv to low parts per trillion by volume (pptv)), 
presence of highly reactive species and high humidity inducing wet chemistry make 
breath samples particularly vulnerable to all problems related to storage [82-84,5,88,89] 
and controlled sampling is therefore a key requirement for reliable analysis of breath 
biomarkers. Actually, there are no accepted standardized methods for on-line or off-line 
VOC breath-gas sampling and analysis. The first guidelines concerning sample collection 
for breath analysis was released in 1999 by the American Thoracic Society for nitric oxide 
(NO) monitoring in breath [90]. Later on, updated guidelines were published in 2005 for 
measurement of NO in mouth- or nose-exhaled breath [91]. In 2005, recommendations 
were also published for exhaled breath condensate sampling and analysis [92]. Hence, 
reproducibility and reliability of sampling methods and analytical measurement 
procedures continue to be of critical importance. 
Many different aspects related to sampling are debated in scientific community, 
such as body posture of the subject when providing the breath sample; hyperventilation; 
control of the flow or volume of breath during collection; sampling via nose or mouth; 
number of breath samples to be taken to reduce variability (single or multiple breaths); 
dilution and contamination of the sample; physiological parameters, such as respiratory 
rate or heart beat rate; alveolar breath or end-tidal volume and dead space; number of 
subjects per study to avoid over-modelling; and direct analysis or sampling for storage 
[86]. Also, temperature dependence influencing the composition of breath samples in off-
line measurements must be taken into consideration [93,94]. The number of issues to be 
considered suggests that the development of several protocols for standardized breath 
sampling may become mandatory. 
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Figure 2.4. A representation of the sampling of (a) breath exhaled via the mouth, (b) breath exhaled 
via the nose and (c) the air in the mouth cavity. The ambient air, exhaled breath or cavity air samples 
pass along the individual plastic sampling tubes and are drawn across the sampling calibrated capillary 
(shown in the enlargement) by the action of the small pump. The in-line needle valve is used to regulate 
the sample ﬂow rate. SIFT-MS indicates the sampling line to the SIFT-MS instrument. (Reproduced from 
Smith et al, Rapid Communication in Mass Spectrometry, 2008 [33]).  
 
2.2.1 End-tidal and Alveolar Breath 
Concentrations of volatile compounds in blood are reflected by their 
concentrations in the exhaled air, depending on their blood-gas partition coefficient or 
solubility. Alveolar breath is air in equilibrium with systemic blood, whereas end-tidal air 
is the last fraction of expired air, whose composition resembles alveolar air. Because the 
alveolar breath is not possible to study non-invasively, the general term “end-exhaled 
breath” is applied because it does not imply that the composition of expired air is always 
identical to the equilibrated air inside the alveoli. It has long been acknowledged that 
alveolar gas exchange is dependent on ventilation, pulmonary perfusion, and the blood:air 
partition coefficient [21], thus, the non-homogeneities in the composition of alveolar air 
among different lung regions over different blood:air solubilities of volatile organic 
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compounds [95]. There is evidence that the gas exchange of highly soluble volatile 
compounds occurs in the airways rather than alveoli [22], meaning that VOCs measured 
at the mouth depend on expiratory flow. Generally, the term alveolar breath may be 
applied for low blood soluble VOCs, whereas for highly soluble volatiles such as acetone 
the term end-exhaled breath should be used due to the evidence that gas exchange occurs 
in the airways rather than alveoli. Such evidence was quantified for the first time by 
Španěl and co-workers, who demonstrated the discrepancy between the concentrations in 
the alveolar region to that in exhaled air [96]. In 1940s W.S. Fowler noted, that the volume 
of exhaled air is a mixture of dead space and alveolar air [97]. Dead space was than 
previously defined as the volume of expired air, which acts as a conducting airway (nose, 
pharynx, larynx, trachea), whereas alveolar air is the expired air fraction that has been 
exchanged in the alveoli. Breath analysis for medical diagnosis relies on end-tidal 
sampling [98], involving the collection of only end-tidal air. Alveolar concentration 
reflects the concentration in blood and consequently, the concentration in blood reflects 
the metabolic processes occurring in the body. Furthermore, there is evidence that better 
reproducibility of data is obtained when only the end-tidal fraction of breath is analysed 
[99].  
The initial strategy for selection of the right part of the exhaled breath for analysis 
was discarding first part (500 mL) of exhaled breath, to avoid dilution of the sample by 
dead space. Nevertheless, because it incorrectly assumes that all subjects have the same 
volume of dead space [100], there was an effort to define another strategy and approach. 
For the on-line analysis has been developed method called buffered end–tidal (BET) 
breath sampling [98]. The purpose of this method is to extend the end-tidal fraction of 
single exhalation. To do so, patient is asked to exhale through a tailored tube, in which 
the end-tidal breath is buffered.  
Nevertheless, in addition to the facts above, it is still difficult to unravel 
concentration of breath molecules prior to mouth appearance, because, in many cases, we 
do not have enough knowledge about the parameters and processes which could affect 
the VOCs´ final concentration in the mouth. For example, highly soluble compounds are 
diluted on their way up from the deeper respiratory track to the airway opening, leading 
to a dilution effect on VOCs’ concentrations (see the chapter below 2.2.2 Dilution and 
Contamination). In addition, changes in ventilation, body posture and stress can have a 
significant impact on the observed breath concentration [3]. 
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2.2.2 Dilution and Contamination 
It was found out, that the exhaled breath concentrations of water soluble 
substances appear to dilute on their way up from the deeper respiratory track to the airway 
opening, leading to discrepancies between the true alveolar breath and the measured 
concentrations, demonstrating a dilution effect. It is because hydrophilic exhaled trace 
gases, such as acetone, interact with the water-like mucus membrane lining the 
conductive airways, an effect known as wash-in/wash-out behaviour [101]. Thanks to 
this, highly soluble gases are present in large concentrations in the airway tissue and 
mucus as compared to less blood-soluble gases for a given partial pressure. In the breath 
analysis the absorption-desorption phenomenon must be also taken into consideration. 
The first step in this process is absorption of soluble gases from the airway wall to the 
inspired air during inspiration. By the time the air reaches the alveoli, the air is saturated 
with the soluble gas and no additional gas exchange occurs. During the next step, 
expiration, a gradient air-to-mucus is established promoting the deposition of soluble gas 
on the mucus and delaying the rise in soluble gas partial pressure at the mouth. For this 
type of gases an anatomic dead space cannot be defined [21,22]. 
Perfusion (diffusion through the airway wall) and temperature are another 
important phenomena influencing the airway gas exchange. Perfusion is driven by the 
bronchial blood flood, meaning that an increase in blood flow increases the amount of 
blood soluble gas in the exhaled breath.  The relationship between the exhaled and inhaled 
breath concentrations have been investigated in the past for seven different compounds, 
whereas gathered results were in compliance with previous models [96]. 
 
2.2.3 Sampling of single or multiple breaths 
Number of breath samples is another important aspect discussed in connection 
with the breath analysis, whereas breath sampling can be performed for single breath or 
multiple breath cycles [98,102,103]. The second option is that more preferred in order to 
acquire reproducible breath samples. Composition of a single breath may not be a 
representative alveolar gas sample for the reason that breaths may considerably vary from 
each other due to different modes and depth of breathing.  
Breathing patterns [3] have been studied and measurements, such as mouth 
pressure, tidal volume, respiration rate, end-tidal carbon dioxide, and mixed expired 
carbon dioxide, were recorded. Paced breathing [3] profiles showed reduced breath 
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variability, according to mass and respiration rate. The authors suggested that controlled 
breathing would prevent hyperventilation, reducing variability in ventilation. 
 
2.2.4 Storage, stability and sampling containers for breath analysis 
Direct sampling is preferable to storage for later analysis. This way the 
decomposition of samples or loss of compounds by diffusion is avoided. When direct 
analysis is not possible, the appropriate storage of exhaled breath is an important issue to 
consider, as was already mentioned above.   
Several types of materials, such as rigid sample containers (gas tight syringes, 
glass bulbs, stainless steel canisters) or flexible sampling bags, can be used for sampling 
and storing of breath samples. Each of these containers is than characterized by certain 
advantages, but also disadvantages.  
In the recent years are for the breath analysis increasingly preferred polymer 
sampling bags, e.g. Tedlar (PVF, polyvinyl fluoride), Tefon (PTFE, 
polytetrafuoroethylene), Nalophan (PET, polyethylene terephthalate) and metal-coated 
multilayer bags (Flexfoil and polyester aluminium (PEA)) [104,105]. This is due to their 
moderate price, inertness, relatively good durability and reusability. Unfortunately, there 
are also some challenges in connection with these containers, especially the phenomena 
affecting sample composition like permeation through the bag walls, 
reversible/irreversible adsorption and pollutants emission from bags ﬁlm. The pros and 
cons of individual polymer sampling bags are, of course, slightly different depending on 
the material characteristic. Tedlar, currently one of the most popular and commonly 
accepted materials (especially in the USA) [82,83,104,106-113] is very robust in use, but 
suffer from background odor concentrations of typically >80 ouE /m3 (European odour 
unit = One ouE  is the mass of pollutant that, when evaporated into 1 m3 of odourless gas 
at standard conditions results in a mixture with concentration equal to the olfactory 
threshold for that pollutant). This is caused by use of a solvent during production [114]. 
Teﬂon bags are quite inert but not very robust in use and are quite costly, which in practice 
almost rules out one-time use. Nalophan bags have been evaluated in the previous studies 
as best choice for the collection of breath samples in terms of contaminants released 
during storage (Nalophan sampling bags are considered to be containers with the perfect 
background, because in the previous studies focusing on this aspect, no or just few 
impurities have been detected), good sample stability (up to 24 hours for both dry and 
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humid samples), and very limited costs (great advantage, allowing one-time use followed 
by disposal) [112,115]. Unfortunately, the material is not always easy to obtain in smaller 
quantities and needs to be stored for some time to reduce background odours. Nalophan 
impurities have been investigated also as part of my work and are in detail discussed in 
section 4.5 Challenges in connection with breath analysis - Nalophan sampling bags. 
 
 
 
 
Figure 2.5. Nalophan sampling bag composed of (a) stopcock, (b) PTFE tube, and (c) Nalophan bag. 
(Reproduced from Ghimenti et al, Journal of Breath Research, 2015 [115]).  
 
In addition to these polymer sampling bags are on the market available also 
multilayer bags, claiming reduced diffusion. These bags use one of the chemically inert 
materials mentioned previously as an inner layer, combined with metalized ﬁlm layers to 
reduce diffusion and permeation. Examples are the metalcoated multilayer Tedlar (MMT) 
bag and the Cali-5-bond were bag [116,117]. 
Number of VOCs have been previously assessed in term of their stability in 
individual polymer sampling bags by PTR-MS, SIFT-MS or GC-MS 
[93,112,113,115,118] to determine optimal solution and material for any category. It was 
investigated that smaller samples are more vulnerable to VOCs losses by permeation. 
Additionally, the volume of the sample collected affects the stability of the sample, thus, 
   
41 
Mochalski and co-workers recommended sample collections as large as possible to 
prevent background emissions of contaminants [118].  
Humidity also affects the species recoveries, and the high humidity in exhaled 
breath might cause significant decrease in vapour concentrations for those compounds 
highly miscible with water [118,113]. Water vapour diffuses through most bags at a speed 
dependent on the temperature of the bag material [93]. Such findings can easily be tracked 
by exploiting the full capabilities of SIFT-MS to measure the water vapour in air/breath 
samples. Condensation affects the sample authenticity, especially for water-soluble 
compounds. The loss of volatile compounds to condensed water in Tedlar bags used for 
breath sampling has been previously evaluated [119] showing differences between dry 
and wet matrices smaller than 10%. For VOCs with molecular mass above 110 amu, 
higher losses were detectable (20%–40%) [118]. It is therefore recommended , to store 
breath samples in pre-conditioned Tedlar bags up to 6 h at the maximum possible filling 
volume.   
 
2.3 Applications 
Although the majority of breath tests has not been integrated in clinical practice, 
there are some applications of breath gas analysis, which are part of the routine practice.  
They include for example breath ethanol test for blood alcohol concentration 
detection (widely used by law enforcement officials world-wide) [120], and additional 
approved tests falling into two basic categories: tests that quantify molecules in breath 
after administration of a drug or substrate; and tests that quantify molecules in breath 
without any prior administration of a drug or substrate.  
 
Table 2.1. The most developed clinical breath tests. 
Breath Carbon Dioxide Test for capnography  
Breath Carbon Monoxide Test for neonatal jaundice  
Breath Ethanol Test for blood ethanol (law enforcement)  
Breath Hydrogen Test to detect disaccharidase deficiency (thus for example lactose, 
maltose or sucrose intolerance), fructose malabsorption, gastrointestinal transit time, 
bacterial overgrowth, intestinal stasis  
Breath Nitric Oxide Test for asthma therapy  
13CO2 functional Breath Tests  
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The first group of tests is based upon the detection of a metabolite of the drug or 
substrate. Carbon dioxide is the most popular metabolite; however, since it is one of major 
products of cellular metabolism, the drug or substrate must be labelled with carbon (13C 
or 14C). Spectroscopic or radiochemical methods can be used to separate and analyse 
labelled carbon dioxide in the presence of unlabelled carbon dioxide. The relatively large 
natural abundance of 13C limits the sensitivity of this method. Breath tests based upon this 
approach require that the metabolism of the substrate and the excretion of carbon dioxide 
are well characterized. Moreover, the breath test must be performed under defined 
conditions based upon the time of administration of the substrate and the time the breath 
test is administered. Additionally, the ventilation pattern of the patient must be carefully 
controlled. Table 2.2 summarizes clinical breath tests that have been proposed based upon 
the quantification of labelled carbon dioxide. Most of breath tests are diagnostic for liver 
function or for gastrointestinal tract function. The breath hydrogen test (Table 2.1) to 
detect disaccharidase deficiency, gastrointestinal transit time, small bowel bacterial 
overgrowth [121] and intestinal stasis is similar to these tests (Table 2.2), since it involves 
the metabolism of a substrate (a carbohydrate, usually lactose) by colonic bacteria. In 
people, who are lactase deficient, lactose is not absorbed in the small intestine and is 
therefore, metabolized in the colon. Since the production of hydrogen in a fasting state of 
normal subject is low (resulting in a breath concentration of less than 42 ppmv) it is not 
necessary to isotopically label the diagnostic disaccharide. However, it is important to 
conduct the breath hydrogen test under carefully controlled conditions, since the time for 
the maximum evolution of hydrogen will depend upon gut motility and this time is critical 
to the test. The breath ethanol test is also similar to the other breath tests contained in 
Table 2.2, since it involves the measurement of a molecule whose origin is supposed to 
be exogenous. Metabolism by enteric bacteria can also produce breath ethanol, although 
the amount generated by this source is orders of magnitude less than an exogenous source.  
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Table 2.2. The clinical breath tests based upon labelled substrates. 
Substrate Clinical test 
Acetate  Orocecal transit time  
Aminopyrine  Liver function 
Caffeine  Liver function 
Erythromycin  Liver function 
Galactose  Liver function 
Glucose  Insulin resistance 
Glycosyl ureides Orocecal transit time 
Ketoisocaproate  Liver mitochondrial function  
Linoleic acid  Fatty acid metabolism  
Methacetin  Liver function  
Methionine  Liver mitochondrial function  
Phenylalanine  Phenylalanine hydrolase activity  
Triolein  Fat malabsorption 
Uracil Dihydropyrimidine dehydrogenase activity 
Urea H. pylori bacterial infection [122] 
 
The second group of breath tests is based upon the detection molecules that are 
produced endogenously as a result of normal or abnormal physiologies. Table 2.3 has 
listed a number of molecules with known biochemical pathways that have been detected 
in human breath and yet only few of these endogenously produced molecules are 
monitored in the tests listed in Table 2.1. The interesting example can be capnography, 
real time measurement of the carbon dioxide concentration profile (most widely used 
clinical breath test, which is used to monitor every patient undergoing surgery or in an 
intensive care unit). Capnography provides important information on cellular 
metabolism, carbon dioxide transport and pulmonary ventilation (exchange of carbon 
dioxide for oxygen, and assessment of airway integrity). Each of these processes is critical 
to monitoring the well-being of a patient. To this group belongs also measurement of 
nitric oxide originating from cells present in the airway, the application important for 
asthma detection [11, 12].  
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Table 2.3. Physiological origin s of some endogenous breath molecules 
Compound Physiological basis 
Acetaldehyde  Ethanol metabolism  
Acetone  Decarboxylation of acetoacetate 
Ammonia  Protein metabolism, oral bacteria  
Carbon disulfide  Gut or oral bacteria 
Carbon monoxide  Production catalyzed by heme oxygenase 
Carbonyl sulfide  Gut bacteria  
Ethane  Lipid peroxidation  
Ethanol  Gut bacteria  
Ethylene  Lipid peroxidation  
Hydrocarbons  Lipid peroxidation/metabolism  
Hydrogen  Gut bacteria  
Isoprene  Cholesterol biosynthesis  
Methane  Gut bacteria  
Methanethiol  Methionine metabolism 
Methanol  Metabolism of fruit  
Methylamine Protein metabolism  
Nitric oxide  Production catalyzed by nitric oxide synthase  
Pentane Lipid peroxidation 
 
A great effort is also being made to integration of new diagnostic tests. Some 
interesting examples of application, divided into categories as per the disease aetiology 
(liver and inflammatory and infectious diseases, cancer, food intolerances), are discussed 
and summarized below. Revelation of diabetes via elevated concentrations of acetone in 
the breath of patients suffering by this disease [6,7], monitoring of renal disease and 
potentially also dialysis via added ammonia [8-10] are the examples already mentioned 
in the introduction.  
 
2.3.1 Cancer 
Very interesting investigation in connection with breath analysis is focused on 
several cancers, for example lung cancer, colorectal cancer, esophago-gastric, bladder, 
breast or prostate cancer. For most of these cancers it is common, that detection by 
standard methods as computer tomography (CT) scanner, magnetic resonance imaging 
(MRI) or biopsies is not effective at an early stage due to the lack of sensitivity. Therefore, 
the determination of possible cancer biomarkers for these diseases would be very 
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desirable and SIFT-MS and PTR-MS have, therefore, been tested to determine whether 
they have potential for their identification. 
 
2.3.1.1 Lung Cancer 
 
  Lung cancer is the most common cancer worldwide (2 million new cases each 
year) and it has one of the lowest survival outcomes of any cancer. It is because over two-
thirds of patients are diagnosed at a late stage when curative treatment is not possible.  
Lung cancer needs to be recognized at a very early stage of growth of the tumours if 
therapeutic intervention is to cure the condition or improve the prognosis. The growing 
interest is therefore being given by physical scientists and clinicians, in harness, to the 
search for volatile biomarkers of tumours in exhaled breath. Over the last two decades, 
most use has been made of GC-MS by Phillips at all [123-125].  This group has advanced 
this topic to the point, that the patterns of trace compounds, especially long-chain and 
branched-chain alkanes, have been observed in the breath of patients suffering from lung 
cancer in different patterns than for healthy control. Methylated hydrocarbons are 
proposed for lung or breast cancer biomarkers [126]. One of the additional biomarkers 
mentioned in connection with lung cancer is the acetaldehyde. The presence of this 
compound in the breath above physiological concentrations (in mean 22 ppbv) [32] could 
have major clinical importance. However, these concentrations in breath may not be 
obvious in most of the cases. Acetaldehyde is an intermediate in the metabolism of 
ethanol in the liver, however, intake of alcohol will greatly elevate acetaldehyde 
concentrations in breath [37]. In addition, acetaldehyde can also be produced from 
cellular activity involving sugars. 
To support lung cancer studies, cells in vitro studies were performed in order to analyse 
the molecular emissions from cancer cells lines SK-MES and CALU-1. The earliest study 
revealed, that acetaldehyde is present in the headspace above incubated SK-MES and 
CALU-1 lung cancer cell cultures at concentrations significantly higher than 
physiological levels [127]. However, studies of Filipiak and co-workers led to conflicting 
results - it was seen that acetaldehyde was produced by the CALU-1 and NL20 cells, but 
absorbed from the medium by the 35FL121 Tel+ cells [128]. Based on this fact the SIFT-
MS studies on CALU-1 cells have been repeated and extended to include NL20 normal 
lung epithelial cells and 35FL121 telomerase-positive (Tel+) lung fibroblast cells. Thus, 
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SIFT-MS has been used to quantify acetaldehyde and, in addition carbon dioxide in the 
headspace of the cell cultures [129]. The results showed that acetaldehyde was generated 
by the CALU-1 and NL20 cell cultures in proportions to the number of cells in the 
medium. However, following incubation, the acetaldehyde concentrations in the 
headspace of the 35FL121 Tel+ cell cultures were much lower than those present in the 
headspace of the medium alone. The amount of CO2 generated by the CALU-1 and 
35FL121 Tel+ cells indicated that they were respiring normally, but much less were 
produced by the NL20 cells, presumably indicating that normal cell metabolism was 
inhibited. These rather perplexing results indicated that acetaldehyde release is not 
specifically the action of malignant cells and so this compound alone cannot be used with 
confidence as a tumour diagnostic.  However, an interesting discovery was made for 
acetic acid (elevated in the breath samples of the cancer patients compared with healthy 
control) [130]. The 3D model for cell lines cultivation has been also tested in which the 
cells were cultured in 3D scaffolds composed of collagen type I hydrogels, compared to 
2D models where cells are grown on surfaces such as plastic or glass. Quantification by 
SIFT-MS of cells lines headspace CALU-1 and non-malignant lung cells NL20 revealed 
that the amount of acetaldehyde released by both cell types grown in a 3D model is higher 
when compared to that of the same cells grown in 2D models [131]. The latest 
investigation on the field of cells in vitro studies was focused on quantification of 
volatiles, propanal, butanal, pentanal, hexanal, heptanal and malondialdehyde 
(propanedial), that are expected to be products of cellular membrane peroxidation [132]. 
All six aldehydes were identified in the culture headspace, each reaching peak 
concentrations during the time of exposure to reactive oxygen species and eventually 
reducing as the reactants were depleted in the culture. Pentanal and hexanal were the most 
abundant, reaching concentrations of a few hundred parts-per-billion by volume, ppbv, in 
the culture headspace. 
 
2.3.1.2 Colorectal Cancer 
 
  Colorectal cancer is again a kind of common cancer (1.4 million new cases each 
year), where the breath analysis could be very promising diagnostic tool. It is attributed 
to individual genetic predisposition and environmental factors, including lifestyle 
(elevated body mass index, BMI, obesity, low physical activity) and diet. The 
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investigation concerning influence of diet revealed, that it can significantly influence and 
promote the growth of malignant cells. Particularly processed and red meat intake, where 
protein is the major constituent leading to protein fermentation metabolites potentially 
carcinogenic and possible linked to colon cancer [133–137], or alcohol’s consumption, 
where metabolites can have multiple molecular consequences that can again instigate 
colon carcinogenesis [138-139], because its oxidative and non-oxidative metabolism, and 
formation of by-products, such as reactive oxygen species and metabolites, can lead to a 
constellation of genetic, epigenetic, cell signalling, and immune processes [139]. The diet 
has therefore complex effects on the generation of breath compounds [140] and therefore 
is very important to understand the normal metabolism and describe the VOCs generated 
under standard body conditions and effect of dietary constituents, whereas the effect of 
diet can be again mediated by many factors (changes of gastrointestinal flora, gastro-
caecal transit time, metabolism, systemic inflammation, redox state). The dietary and 
metabolic sources of the main metabolites in human breath are available in Figure 2.5. 
In the past there were studies evaluating breath samples from patients with colorectal 
cancer, concluding that the pattern of VOCs in patients suffering from colorectal cancer 
were different from that in healthy controls, particularly concentrations of some specific 
VOCs such as  1,3-dimethylbenzene, 1,2-pentadiene, cyclohexene and 
methylcyclohexene [141]. However, much more research is necessary to support this 
investigation.  In connection with this topic is also important to mention, that VOCs 
generated by the metabolism may emanate also from faecal matter. Thus, analyses of 
human metabolites as end products of intestine may rely on faecal samples or on breath. 
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Figure 2.6. Dietary and metabolic sources of the major metabolites in human breath. (Reproduced 
from Ajibola et al., Journal of Nutritional Science, 2013 [140]). Gastrointestinal (GI); fructose 1-
phosphate (F1P); glucose 6-phosphate (G6P); glucose 1-phosphate (G1P); long-chain fatty acids (LCFA); 
branched-chain fatty acids (BCFA); hydroxy methyl glutaryl (HMG); carbomyl P, carbomyl phosphate. 
The grey boxes represent compounds that have been identified in breath. 
 
2.3.1.3 Esophago-Gastric Cancer 
 
Gastro-esophageal cancer is the 7th most commonly occurring cancer in men and 
the 13th most commonly occurring cancer in women. There were over 500,000 new cases 
in 2018. Same as lung cancer, gastro-esophageal cancer remains a disease with poor 
patient outcomes. It is again because of above mentioned fact that red ﬂag symptoms 
often occur at a more advanced stage of the disease, and therefore, people with such 
cancers most commonly go to their doctor later in the disease process. This delay in 
diagnosis results in only 20% of patients being suitable for potentially curative treatment 
at ﬁrst presentation. One of the main methods for improving these survival rates lies in 
the earlier detection of these cancers, and VOC analysis represents a promising area to 
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explore in relation to gastro-esophageal cancer. In this field, four important studies have 
been conducted, investigating interesting VOCs in breath or headspace vapour of 
biofluids at different patient groups and healthy controls. The first study on the headspace 
of gastric content, conducted by Kumar et al in 2012, indicated that the combinations of 
the following 7 VOCs, acetone, formaldehyde, acetaldehyde, hexanoic acid, hydrogen 
sulphide, hydrogen cyanide, and methyl phenol are significantly diﬀerent between cancer 
patients and healthy control group [142]. In the follow-up study investigating VOCs in 
the headspace of urine, the concentrations of seven VOCs, acetaldehyde, acetone, acetic 
acid, hexanoic acid, hydrogen sulﬁde, methanol, and phenol, were found to be 
signiﬁcantly diﬀerent between cancer, positive control, and healthy groups [143]. The 
results of these studies identiﬁed potential compounds that may be important in VOC 
proﬁling of esophago-gastric cancer and thus warrant further investigation. In the next 
steps, VOCs within exhaled breath have been identified, because it was hypothesized that 
several of the VOCs detected at increased concentrations in the headspace of bioﬂuids 
from esophago-gastric cancer patients may be present in the exhaled breath of these 
patients. In the first study focused on breath the compounds for analysis (a total of 17 
VOCs) have been selected based on their presence in bioﬂuids in previous studies on 
esophago-gastric cancer or if they have been detected in other cancer states. The 
concentrations of 4 VOCs, hexanoic acid, phenol, methyl phenol, and ethyl phenol, were 
found to be signiﬁcantly diﬀerent between cancer and positive control groups [144].  
Further study with large patient cohorts has been conducted by Kumar et al in 2015. 
Exhaled breath samples were analysed from 81 patients with esophageal or gastric 
adenocarcinoma and 129 controls. Twelve VOCs from the family of fatty acids, phenols 
and aldehydes (namely pentanoic acid, hexanoic acid, phenol, methyl phenol, ethyl 
phenol, butanal, pentanal, hexanal, heptanal, octanal, nonanal, and decanal) have been 
identified as potential breath biomarkers in esophageal adenocarcinoma and it was 
concluded that distinct exhaled breath VOC profiles can distinguish patients with 
esophageal and gastric adenocarcinoma from non-cancer controls [145].   
 
2.3.1.4 Breast Cancer 
 
Breast cancer (1.7 million new cases per year) is accompanied by increased 
oxidative stress and induction of polymorphic cytochrome P450 mixed oxidase enzymes 
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(CYP). Both processes affect the abundance of VOCs in the breath because oxidative 
stress causes lipid peroxidation of polyunsaturated fatty acids in membranes, producing 
alkanes and methylalkanes, which are catabolized by CYP. Compounds from this group, 
among others, nonane, 5-methyltridecane, 3-methylundecane, 6-methylpentadecane, and 
2-methylpropane, 3-methylnonadecane, 4-methyldodecane, 2-methyloctane, have been 
suggested as potential biomarkers by Phillips and co-workers. They performed a pilot 
study (GC-MS) of breath VOCs in women with breast cancer, whereas results have been 
compared with abnormal mammograms and biopsies. The breath test distinguished 
between women with breast cancer and healthy volunteers with a sensitivity of 94.1% 
[146]. Their recent findings were consistent with previous studies, as they indicated that 
breath contains volatile biomarkers of breast cancer and that these biomarkers can identify 
woman with disease. However the biochemical origin of volatile biomarkers of breast 
cancer remains speculative [147]. As another promising breast cancer biomarker has been 
identified also pentane, which has been found in increased concentrations in the breath of 
woman with this disease - an initial case-control study performed by Hietanen and co-
workers [148]. 
 
2.3.1.5 Bladder and Prostate Cancer 
 
Exhaled breath testing for prostate (1.1 million new cases per year) and bladder 
cancer (0.4 million new cases per year) is another topic that deserves attention. Even in 
case of this cancer disease, there is a pressing need for non-invasive diagnostic tool that 
would be suitable for discrimination between patient with and without this illness. As a 
potential biomarker for tumours identified in 1999 Španěl and co-workers formaldehyde. 
They conducted a SIFT-MS study, which showed that this compound is elevated in the 
headspace of urine donated by bladder and prostate cancer patients, whilst being absent 
from the headspace of the urine from healthy controls [149]. It was also found, that the 
formaldehyde is at a greater concentration in the urine from the bladder cancer patients 
than in the urine from prostate cancer patients. This is perhaps not surprising in that 
bladder tumours are in closer contact with the urine whereas the formaldehyde from 
prostate tumours must generally progress into the urine via the blood stream [150]. In the 
recent years, there is also an effort to simplify the breath testing methods and therefore 
electric nose devices have been tested as possible devices for non-invasive diagnostic. As 
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an example, we can mention the study of Waltman and co-workers, where the prostate 
cancer diagnostic have been conducted by utilisation of Aeonose, a handheld, battery-
powered electronic nose (EN). The exhaled breath is in this device guided over three 
hotplate metal–oxide sensors, namely carbon monoxide (AS-MLC), nitrogen dioxide 
(AS-MLN), and VOC (AS-MLX) sensors, where the VOCs induce a redox reaction on 
the hotplate of sensor surface, causing the change in conductivity. This redox reaction is 
dependent on the compound, surrounding gas, sensor surface and surface temperature. In 
order to distinguish between different VOCs more accurately, the hotplate sensors go 
through a sinusoidal temperature cycle (260–340°C) during an interval of approximately 
20 s. A measurement consists of 36 of these intervals, creating a temperature-speciﬁc 
VOC proﬁle. A metal-oxide sensor measures the response of redox reactions over a 
certain time period in a thermal cycle, which causes a three-dimensional data matrix (time 
vs thermal cycle vs response value). Exhaled-breath analysis using an EN (Aeonose) in 
order to differentiate between Prostate Cancer patients and healthy individuals yielded 
very promising results [151]. 
 
2.3.2 Liver disease 
Sulphur containing compounds like methyl mercaptan, ethyl mercaptan, 
dimethylsulfide or dimethyldisulfide and nitrogen containing compounds such as 
amines/ammonia are proposed to be characteristic biomarkers for this area, as they 
correlate respectively with liver diseases [152,153].  
Sulphur containing compounds are generated in humans by incomplete metabolism of 
methionine in the transamination pathway [153]. Their concentrations in human blood 
and breath are very low under healthy conditions, nevertheless, impairment of liver 
function increases their level [154]. Sulphur containing compounds are responsible for 
the characteristic odour in the breath, for example at cirrhotic patients [152]. The 
characteristic odour of dimethylamine and trimethylamine has been known for a long 
time [155]. Significant concentrations of ammonia will appear in the blood if ammonia 
through conversion to urea is limited due to an impairment of liver function (for example 
cirrhosis or severe hepatitis. The majority of ammonia seen in mouth-exhaled breath is, 
however, largely generated in the oral cavity [33].  
The possible use of VOCs in patients with liver cirrhosis is not fully explored area. 
An initial study performed by Van den Velde and co-workers [156] showed 
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discrimination between the cirrhotic group and healthy subjects. They analysed the breath 
of 50 patients with established liver cirrhosis. Recently, a pilot study using PTR-MS 
equipped with a time-of-flight mass analyzer was conducted in liver cirrhosis patients by 
sampling the breath of the subjects [157]. The authors were able to distinguish between 
healthy and disease subjects. They identified twelve VOCs significantly different 
between cirrhotic and healthy subjects (ketones, terpenes, sulphur compounds, nitrogen 
compounds and alcohols). Volatile biomarkers in breath associated with liver cirrhosis 
have been studied also by Fernández del Río and co-workers [158]. This working group 
compared pre- and post-liver transplant breath samples and identified five volatiles with 
statistically significant decrease post-transplant (limonene, methanol, 2-pentanone, 2-
butanone and carbondisulﬁde). On an individual basis limonene showed the best 
diagnostic capability, but it was improved by combining methanol, 2-pentanone and 
limonene. Following transplant, limonene shows wash-out characteristics [158]. 
Another liver disease, where attempts have been made to use breath analysis for 
detection purposes, is hepatic encephalopathy [159], neuropsychiatric syndrome with 
symptoms varying depending on the severity of the condition. This disease results from 
the accumulation of compounds not cleared by the liver and again ammonia is known to 
be involved in hepatic encephalopathy [159]. However attempts to use breath ammonia 
measurements for diagnosis have failed, probably because most exhaled ammonia is 
generated within the oral cavity by bacterial and/or enzymatic [33]. Additionally, some 
confounding factors have proven to be tricky in VOCs detection and quantification. For 
example, pulmonary gas exchange abnormalities can be present in patients with advanced 
liver disease, such as high cardiac output and abnormal dilation of pulmonary capillary 
vessels, leading to incorrect conclusions [159]. 
 
2.3.3 Inflammatory bowel disease 
Ulcerative colitis (UC), together with Crohn's disease (CD), are a part of the 
spectrum of inflammatory bowel diseases (IBDs) - the class of autoimmune disorders in 
which the body’s own immune system attacks parts of the digestive system [160-163]. It 
is a chronic inflammatory condition with unknown aetiology and only a partially 
understood pathogenesis. The consensus is that both diseases are a response to 
environmental triggers (infection, drugs, or other agents) in genetically susceptible 
individuals [164].  
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This group of disorders causing inflammation of the gastrointestinal tract (GIT), 
is recently in the focus of several areas of research, besides others also breath analysis 
[165-169]. The reasons are increasing incidence and prevalence of these inflammatory 
conditions in Europe [170], lack of a single gold standard and multimodal approach for 
the diagnostics and differentiation. Moreover, most of the currently used diagnostics 
methods are either invasive or have limited sensitivity or specificity [171-174].  
CD is characterized by chronic discontinuous transmural inflammation that may 
involve any portion of the gastrointestinal tract, but most commonly the terminal ileum, 
whilst UC is characterized by inflammation of the colonic mucosa, extending to a variable 
extent from the rectum to the proximal colon. With regard to clinical features and pattern 
of IBD, the cardinal symptom of UC is bloody diarrhoea. Associated symptoms of colicky 
abdominal pain, urgency, or tenesmus may be present as well. Symptoms of CD are more 
heterogeneous, but typically include abdominal pain, diarrhoea, and weight loss. To date 
there is no cure for IBD, but current medical therapy alleviate the distressing symptoms 
in the most patients and reduce the mortality, which is greatest in the 2 years after 
diagnosis for both, UC and CD  [175-178].  
In the past, there was an effort to utilize breath analysis as a method for IBD 
detection – differentiation between IBD suffering people and healthy control, but also 
between CD, UC and between active disease and disease in remission. 
One of the pilot studies in this area, conducted by Dryahina and co-workers has 
been focused on detection of exhaled pentane concentration as a biomarker of lipid 
peroxidation [168]. The results of this study revealed that breath pentane is significantly 
elevated in the breath of both, CD patients and UC patients relative to healthy controls, 
being at somewhat lower mean concentration in UC than CD breath. However, as pentane 
is a nonspecific inflammatory marker, it was important to add other volatile metabolites 
to the panel of compounds used for breath test of the IBD disease activity.  
The method for the diagnosis of IBD, differentiation between CD and UC and 
active/remission states by detecting different VOCs in exhaled breath has been patented 
by the group of inventors leaded by Dallinga [179-182]. These patents have prompted 
further research in this area, and SIFT-MS study of selected VOCs previously identified 
by other research groups as being present in modified concentrations in the breath of 
patients with IBD, has been conducted [165] by our investigative team (see Appendix B 
for additional details). Data obtained in this experiment, aimed besides others at 
quantification of some hydrocarbons, have shown some interesting results for alkenes, 
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specifically elevated ion signal at m/z 99 observed in the H3O+ SIFT-MS analyses of 
breath of IBD patients [183] that may be characteristic for heptene. These observations 
in conjunction with the study of Patel et al. [167], which supported the hypothesis that 
alkenes are possible IBD biomarkers, caused that a detailed study of the ion chemistry of 
alkenes focusing on heptenes has been conducted [169]. The study resulted in ion-
molecule kinetics data (effectively addition of several entries to a SIFT-MS library) for 
alkenes, which would ultimately allow fast SIFT-MS analyses of breath samples and the 
quantification of alkenes for the purpose of IBD diagnostics (see Appendix C for 
additional details).  The additional research is ongoing in this area and some recent results 
are discussed in the experimental part of this thesis (see section 4.4 Breath analysis and 
searching for the new biomarkers). 
 
2.3.4 Bacterial infections - Tuberculosis, Cystic fibrosis 
complications 
Pulmonary tuberculosis (TB) is an infectious disease derived from the organism 
Mycobacterium tuberculosis. The primary detection technique is the Ziehl-Neelsen 
staining combined with microscopy. It only allows detection of pulmonary disease in an 
advanced stage, meaning that often the disease has already been transmitted to close 
contacts. Breath analysis may offer a method for diagnosing pulmonary tuberculosis 
[184]. Some compounds potential biomarkers have been found by breath sampling, such 
as methyl phenylacetate, methyl  p-anisate, methyl nicotinate, and o-phenylanisole [185]. 
However, contradictory studies presented different marker compounds, possible due to 
the fact that Mycobacterium tuberculosis is a slow growing organism. This means that if 
VOCs are produced they may be released or modified by the host, hence, they may well 
be present at low concentration and not be detected by the real-time analytical techniques. 
The best approach should be looking at clinical samples in order to get potential 
biomarkers of pulmonary tuberculosis [5]. 
Breath analysis offers great potential as a non-invasive method for diagnosis of 
lower respiratory tract infections without the need for bronchoscopy or alveolar lavage 
[186]. Therefore could be utilized as a diagnostic tool with a great value also in 
connection with cystic fibrosis (CF), an inherited genetic disease caused by mutations in 
a gene that is responsible for the transfer of ions and salts across the cell membrane [187-
189]. In CF the early detection of respiratory pathogens such as Pseudomonas aeruginosa 
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(PA) and Burkholderia cepacia, which are the major cause of morbidity and mortality in 
patients with this illness [190-191], increases the chance of their eradication. The reason 
why a non-invasive breath test would be of a special beneﬁt (particularly to children) is 
that they are often unable to reliably expectorate sputum, cultivation of which is the gold 
standard method for PA diagnosis.  This approach offers a way since the detection by 
SIFT-MS of HCN emission from cultures of PA in vitro [192,193]. It was shown that in-
vitro cultures of PA released several VOCs including, and especially, HCN. 
Subsequently, SIFT-MS was used for the analyses of breath of 40 children suffering from 
CF. The concentration of HCN in the exhaled breath was in these patients increased 
significantly in comparison with children who suffered from asthma but not with CF 
[194]. However, in 2011 a SIFT-MS study of HCN in the headspace of 96 genotyped PA 
samples showed that different strains of this bacterium produced different amounts of 
HCN. Also it was observed that the non-mucoid phenotype samples produced more HCN 
than the mucoid phenotype samples [193,195,196].  Based on these facts, the group of 
Shestivska et al. investigated presence of methyl thiocyanate in the headspace of PA 
cultures and subsequently in the breath of CF patients by SIFT-MS [197], as this 
compound has been previously confirmed by the pilot experiment using SPME and GC-
MS analyses.   To wit, cyanide produced by bacteria is toxic and PA avoids its toxicity 
by several enzymatic pathways. One of the recently described mechanisms of 
detoxification of HCN by PA is its metabolism into thiocyanate involving the enzyme 
thiosulphate sulphurtransferase. The study of the exhaled breath of CF patients finally 
indicated that the concentration of methyl thiocyanate is within the range from zero up to 
28 ppbv and that the combination of methyl thiocyanate and hydrogen cyanide could be 
a more robust biomarker of PA and could possibly differentiate different PA strains. The 
research in the field is nevertheless still ongoing. HCN as a CF biomarker has been further 
investigated by Gilchrist and co-workers, whereas studies have been focused for example 
on selection of suitable sampling methodology (mouth vs. nose exhaled breath) [198], or 
on early detection of PA infection detection [199]. In addition, further respiratory 
pathogens connected with CF, as Pseudomonas aeruginosa, Staphylococcus aureus, 
Stenotrophomonas maltophilia and the Burkholderia cepacia complex, and VOCs 
emitted from these cultures have been investigated [200,201]. It was shown, that several 
volatile biomarkers were distinct for one of the four major bacterial taxa that are involved 
in pulmonary infections of patients with CF. This result may reflect substantial 
differences in the cellular metabolisms of these taxa, which are phylogenetically distant 
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from each other [201]. The newest study focused on CF than revealed, that acetic acid 
(AcOH) is elevated in the exhaled breath of CF patients. Breath acetic acid could be 
therefore used as a non-invasive biomarker of the acidity of the airways mucosa, which 
could help to assess the risk of bacterial infection (none of the bacterial pathogens et al. 
are producing AcOH and that its concentration is not related to mucus build-up, it is most 
likely that the airway mucosa has a lower pH relative to normal respiratory tract mucus 
due to the loss of the cystic fibrosis transmembrane conductance regulator gene) and 
ultimately improve  the efficacy of CF therapy. It may be that measurement of AcOH in 
exhaled breath could support CF diagnosis alongside the standard tests. Clearly, further 
work is needed to substantiate these findings using greater cohorts of healthy volunteers 
and CF patients [202,203]. 
 
2.3.5 Food Intolerances, autoimmune disorders  
Food intolerance, also known as non-immunoglobulin E (non-IgE) mediated food 
hypersensitivity or nonallergic food hypersensitivity, refers to difficulty in digesting 
certain foods. It is important to note that food intolerance is different from food allergy 
(food allergies trigger the immune system, while food intolerance does not). Foods most 
commonly associated with food intolerance include dairy products, grains that contain 
gluten, and foods that cause intestinal gas build-up, such as beans and cabbage. 
Recently, hydrogen breath test (HBT) has become popular in clinical practice as 
it is useful for diagnosis carbohydrate intolerance such as lactose and fructose 
malabsorption. [204-206], a condition in which the patients are unable to absorb or digest 
certain carbohydrates due to the lack of some intestinal enzymes, leading to bacterial 
sugar fermentation in the gut.  
Coeliac disease is a long-term, under-diagnosed autoimmune disorder that 
primarily affects the small intestine. Classic symptoms include gastrointestinal problems 
such as chronic diarrhoea, abdominal distention, malabsorption, loss of appetite and 
among children failure to grow normally. Coeliac disease is caused by a reaction to 
gluten, a group of various proteins found in wheat and in other grains such as barley and 
rye. A preliminary investigation of the concentrations of alcohols in the breath of 10 
patients with coeliac disease compared to that in 10 healthy controls using SIFT-MS has 
been conducted for this disease [81]. No significant conclusions were drawn. Such results 
are in agreement with recent findings performed by Aprea and co-workers [207], where 
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real time breath analysis was performed in patients diagnosed with coeliac disease under 
gluten free diet. As expected, exhaled breath of patients with coeliac disease was similar 
to the exhaled breath of healthy people and no reliable marker was found. 
 
2.3.6 Transplant rejection 
The utilisation of breath analysis for early transplant rejection is a topic very often 
mentioned in relevant papers focused on breath analysis applications. From our point of 
view are results achieved in this area a little uncertain. Distrust is supported also by the 
fact, that no recent studies or works focused on this area are available. Nevertheless, to 
achieve completeness of the theoretical part of my work, the research conducted with 
regard to transplant rejection is summarised below.  
After organ transplantation, patients have to be treated in the intensive care unit 
(ICU) because of chronic or acute rejection of the transplanted organ and to avoid 
complications due to infection following immunosuppression. Allograft rejection 
following organ transplantation has been linked to alkane exhalation. Pentane 
concentration were found to be elevated in acute rejection of transplanted hearts, 
however, it is important to remember, that pentane as a lipid peroxidation marker is linked 
to inflammation rather than being a specific marker for allograft rejection [208,209]. 
Carbonyl sulfide (OCS) seems to be generated as a by-product of methionine metabolism 
and may act as an acute marker of organ rejection after lung transplantation [210]. This 
volatile marker is not found in the exhaled breath of healthy individuals. A crucial 
problem is the distinction between organ dysfunction due to infection or any other 
complication and organ dysfunction due to organ rejection. Up to now, invasive 
procedures such as biopsy (heart, liver, kidney) or bronchoscopy (lung) were necessary 
for that purpose. Non-invasive breath test could, therefore, be of considerable benefit to 
these patients. In connection with heart rejection has been also evaluated larger repertoire 
of biomarkers of oxidative stress in breath - the breath methylated alkane contour 
(BMAC) [211,212]. The breath test divided the heart transplant recipients into 3 groups: 
positive for grade 3 rejection, negative for grade 3 rejection, and intermediate. The test 
was 100% sensitive for grade 3 heart transplant rejection when the p value was >0.98, 
and 100% speciﬁc when the p value was <0.058; in the intermediate group, the breath test 
determined the probability of grade 3 rejection and the predictive value of the result [212]. 
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3 Techniques for breath analysis 
Volatile metabolite research relies on analytical methods that offer high 
sensitivity, precision and resolution (see Table 3.1). In the last years, great importance is 
given especially to the on-line, real-time analytical techniques SIFT-MS and PTR-MS. 
These methods exhibit limit of detection ranging from ppbv to pptv, making them ideally 
suited to breath analysis [213]. Proton transfer reactions are characteristic for both these 
techniques and are encouraged by the chemical ionization process that allows a very 
efficient ionization for many organic compounds in the gas phase. Product ion generation 
in SIFT-MS and PTR-MS is managed using chemical ionization, arising from ion-
molecule reactions rather than electron impact or photoionization, with much less 
fragmentation of the molecules. Thus, these techniques are called soft ionisation 
techniques.  
In the past, the analysis of volatile trace compounds in air and exhaled breath has 
most commonly been achieved using mass spectrometry (MS) coupled with some form 
of sample preparation and compound separation, as in gas chromatography (GC), and 
exploiting compound ionization by electrons (EI), that is most commonly used in GC-
MS. The analytical mass spectra produced by this ionisation process are nevertheless 
considered as more difficult to interpret (in comparison with analytical mass spectra 
produced by soft ionisation techniques). GC-MS is considered as a gold-standard 
analytical method for breath analysis.  
 
Table 3.1. A comparison of the characteristics of the available breath research techniques. 
Analytical 
Method 
Mode of operation Limit of 
detection 
(LOD) 
Sensitivity Specificity 
SIFT-MS Direct/Real time ppbv High  High 
PTR-MS Direct/Real time pptv High Medium-High 
IMS Real-time ppbv Medium Medium 
Sensor arrays Reference to a database ppbv Medium Medium 
GC-MS Pre-concentration pptv-ppbv Very-high Very-high 
LAS Real-time ppbv High High 
 
Other analytical techniques that are widely used and play important roles in breath 
analysis are laser absorption spectroscopy (LAS), ion mobility spectrometry (IMS), and 
electronic noses, containing a variety of gas sensors and semiconductor-based sensor 
arrays.  
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Concerning the IMS technique, the ions are generated by a beta emitter or by a 
corona discharge and they are separated according to their mobilities through the gas, 
which is usually air at atmospheric pressure [214]. Such devices are not operated at high 
vacuum conditions and therefore ion-molecule collisions occur, limiting the speed of the 
ions along the drift tube. Hence, the number of ions reaching the detector is lower 
compared to the theoretical value. This is an important factor limiting the sensitivity of 
IMS. During the last ten years it has been applied in medical research, such as detection 
of skin volatiles [215], detection of volatiles in exhaled breath of patients with lung cancer 
[216], and determination of anaesthetics concentration in exhaled breath [217].  
For the LAS technique, the amount of light absorbed by a sample is related to the 
concentration of the target specie in the sample. The LAS-based technique cavity 
ringdown spectroscopy (CRDS) has been successfully applied to measure NO 
concentration in exhaled breath [218]. This technique enables quantification of volatiles 
in exhaled breath down to below parts-per-billion by volume levels. It is particularly 
useful for monitoring purposes, and, recently, the exhaled breath of healthy volunteers 
was assessed by CRDS [219].  
In order to analyse different VOCs, many applications have combined various 
sensors and materials into a single array, leading to the development of an “electronic 
nose” [220]. Sensor technology has been used for many years in clinical testing. 
Currently, the goal consists of finding materials with high sensitivity and good selectivity 
to the VOCs to be detected. Up to now, the existing materials are mostly conductive 
polymers, semiconducting metal oxides, or a combination of these two materials [221]. 
Unique sensors, based on nanoparticles appear as a reliable alternative tool for breath 
analysis, proving to be inexpensive and easy-to-use. The quartz crystal microbalance 
(QCM) and the surface acoustic wave (SAW) device are mass-sensitive sensors which 
have been used in breath analysis [5]. In QCM, gas molecules are adsorbed on the 
crystal’s surface during sensor exposure to a gaseous medium, changing its mass and 
resonant frequency. A selective adsorption of the gas mixture strongly influences the 
degree of crystalline order and by the nanostructure boundaries. The polymer overall 
characteristics, length, planarity of the conjugate polymer chain, and the side chain 
composition may influence the polymer conductivity [221]. Recently, Cr- or Si-doped 
WO3 nanoparticles have shown high sensitivity to acetone, leading to the development 
of a portable chemo-resistance sensor suitable for real-time breath acetone detection 
[222]. Breath acetone concentration of five test persons at rest or during physical activity 
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was measured and compared to that measured by PTR-MS. Si-WO3 sensors were 
selective to acetone in realistic conditions (90% Relative Humidity), and able to detect 
differences in breath acetone concentrations between 880 to 980 ppbv, in agreement with 
PTR-MS measurements.  However, the combination of specificity, selectivity, robustness 
in operation, reproducible manufacturing uniformity, and long-life stability is not offered 
by current sensors at an acceptable cost level. These technologies are unable to identify 
individual compounds, although they can be used to compare samples to see whether they 
have similar VOC profiles. 
Finally is also important to mention for the purpose of breath analysis also Fourier 
transform infrared spectroscopy (FTIR), a chemical analytical technique, which measures 
the infrared intensity versus wave number (wavelength) of light [223]. 
 
3.1 Mass spectrometry  
The origins of mass spectrometry can be traced back to the 19th century to the 
Lord Thompson’s early work on cathode rays – the discovery of electrons for which he 
received in 1906 Nobel Prize in Physics. Later, in 1913 J.J. Thompson, with the help of 
Francis Aston built the first mass spectrometer and resolved neon isotopes and thus they 
are considered to be the founders of mass spectrometry [224]. These fundamental 
developments helped towards a better understanding of the elements and their physical 
properties. 
An important step in the analytical use of mass spectrometry was the combination 
of mass spectrometry with gas chromatography (GC). The modern GC was invented by 
Martin and James in 1952 [225].GC has become a standard analytical method in many 
fields, especially petrochemical manufacture, environmental, biological and food 
sciences, and also in drug residue and forensic analysis. The field of GC rapidly expanded 
in the 1980s.  
As already mentioned above, despite some weaknesses (comparison with 
standards required for absolute quantification, matrix effects, need of extraction or 
adsorbing the VOCs onto a suitable adsorbent [85] and long-term analysis) GC-MS is 
considered to be the gold standard method for analysis of VOCs. The primary objective 
of chromatographic analysis is to achieve the desired separation of compounds in a 
mixture in the shortest possible time. Reductions in analysis time have been achieved by 
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fast GC [226].The principles and theory of fast GC were established in the 1960s, but for 
routine analysis fast GC were used later in 1990s when the adequate commercial 
instrumentation was available [227].Currently is gas chromatography mass spectrometry 
(GC-MS) for the purpose of breath analysis commonly combined with the extraction 
methods of thermal desorption (TD) [228] and the above mentioned solid-phase micro-
extraction (SPME) [85]. GC can be for the purpose of breath analysis connected also with 
UV spectrometry (GC-UV). Nevertheless, GC-MS is most common. 
In 1972 Membrane inlet mass spectrometry (MIMS) was described and gradually 
became a relatively well established technique for monitoring gases and VOCs directly 
from aqueous solutions [229]. But this technique can be considered to be more qualitative 
than quantitative. For quantitative analysis, soft ionisation techniques, like chemical 
ionisation, are preferred. One of the methods for direct sample analysis is atmospheric 
pressure chemical ionisation (APCI) followed by mass spectrometry that was originally 
developed for analysis of trace components in the gas phase [230]. In 1980 trace 
atmospheric gas analyser (TAGA) based on APCI was used in several environmental 
applications, explosive detection and even breath analysis [231] and monitoring of CO2 
[232]. Today, APCI is widely used in analysis of trace gases released by foods [233] and 
many other trace gas analyses down to the parts-per-trillion by volume (pptv) 
concentrations [231]. In spite of their great sensitivity a weakness of APCI methods is 
again in its lack of absolute quantification and also due to matrix effects that compromise 
reproducibility. The state of the art methods stemming from this heritage are extractive 
electrospray ionisation (EESI) [234] and secondary electrospray ionization-mass 
spectrometry (SESI-MS) [235]. 
In the mid-1990s two techniques based on chemical ionization were introduced 
capable of direct real time trace gas analysis: SIFT-MS and PTR-MS.  Both will be 
described in more detail below.  
 
3.1.1 Proton transfer reaction mass spectrometry 
Proton transfer reaction mass spectrometry (PTR-MS) was developed in 
Innsbruck by Lindinger and co-workers [236] mainly for the purpose of detection of both, 
biogenic VOCs and anthropogenic VOCs in atmospheric science, environmental 
research, food and flavour analysis and also breath analysis [237]. Several reviews have 
already been published about this method. The origin of this method is similar to origin 
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of SIFT-MS, both methods can be traced back to flowing afterglow method (FA) [238]. 
PTR-MS is based on chemical ionisation of molecules present in gas sample by reagent 
ions inside a drift tube. It allows real-time, on-line determination of absolute 
concentrations of VOCs, with detection sensitivity greater than SIFT-MS. The first PTR-
MS instruments developed only used H3O+ as reagent ion, a disadvantage compared to 
SIFT-MS. Currently, the latest instruments use a switchable reagent ion capability, 
alternating between the three reagent ions like SIFT-MS. This so-called “Switchable 
Reagent Ions“ (SRI) variant of PTR-MS was introduced in 2009. Since then it is possible 
to switch between H3O+, NO+ or O2+• reagent ions [239], though the switch takes several 
seconds.  
There are usually overlapping ions in clinical sample headspace and the use of 
PTR–MS equipped with a time-of-flight (TOF) mass analyzer improves mass resolution 
to assist ion identification [240,241]. PTR-MS employs an electric field, E, along the flow 
tube axis to increase the velocities of the ions. The change of the ratio E/N, where N is 
the number density of the drift tube buffer gas molecules, will affect the reagent ion 
hydration and product ion fragmentation. Under normal operating conditions E/N is in 
the range 120–130 Td (1 Td ~ 1 Townsend ~10-17 V cm2) representing a compromise 
between reagent ion hydration on the one hand, and molecular (product) ion 
fragmentation on the other. The electric field also prevents the formation of substantial 
quantities of cluster ions. In contrast to SIFT-MS, PTR-MS operates at higher effective 
temperatures and the underlying ion chemistry is often not known [242,243].  The 
instrument is much shorter, due to the existence of a shorter drift tube, has a typical length 
10–20 cm, and, consequently, the pumping system is reduced in size, making PTR-MS 
suitable for transport. However, the latest advances in SIFT-MS have surpassed this issue, 
in which the instrument has become much smaller and suitable for transport [244].  The 
recent advances in PTR-MS technology have demonstrated a diverse range of 
applications, especially for breath gas analysis [245].   
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Figure 3.1. Schematic view of the PTR-MS instrument. (1) is the hollow cathode ion source, (2) the drift 
tube, (3) the transition chamber, (4) the detection chamber containing the quadrupole and the secondary 
electron multiplier (5). Reprinted with permission from F.Harren. (2007). 
3.1.2 Selected ion flow tube mass spectrometry 
3.1.2.1 Selected ion flow tube  
 
Selected ion flow tube mass spectrometry (SIFT-MS) is an analytical technique 
derived from the selected ion flow tube (SIFT), the flow-tube method, conceived and 
developed in 1976 by N. G. Adams and D. Smith [246] for the study of gas-phase 
reactions between ions and molecules. SIFT method is in comparison with the flowing 
afterglow (FA) – the first application of a flow tube, described in 1963 by Ferguson, 
Fehnsfeld and Schmeltekopf  [238] – characterised by presence of a quadrupole mass 
filter after the ion source. Thanks to this can be reagent ions selected according to their 
mass to charge ration (m/z) before injection into fast flowing neutral carrier gas. The SIFT 
technique became a standard tool for the study of the kinetics of the reactions between 
ions and neutral molecules in the gas phase under truly thermalised conditions [247,248]. 
Research in this area was focused on the study of ion-molecule kinetics important to 
atmospheric and interstellar ion chemistry [249]. This work has resulted in a large amount 
of experimental kinetic data for ion-molecule reactions, including rate constants and 
product ion distributions. These data have been a foundation for the use of SIFT-MS for 
analytical purposes, especially for determination of trace gas concentrations in air, with a 
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focus on quantitative analysis of gases in human breath [47,75]. The principles of the 
SIFT technique are illustrated in Figure 3.2. 
 
 
Figure 3.2. SIFT apparatus – historical scheme of the first SIFT instrument build in Birmigham 
university.. (Reproduced from Hyšpler et al., Journal of Chromatography B: Biomedical Sciences and 
Applications, 2000 [39]).  
 
3.1.2.2 Selected ion flow tube mass spectrometry 
 
The SIFT-MS has been developed in 1995 by D. Smith and P. Španěl as a method 
for the analysis of trace gases at ppbv concentrations in atmospheric air, with the focus 
on the detection and quantification of trace gases of biological origin (human breath, 
headspace of biological fluids). The main applications of this method have become 
clinical diagnosis, therapeutic monitoring [250-253] and physiological studies 
[9,47,253,254]. Traditionally, the SIFT instruments were large apparatuses filling the 
whole laboratory. In 1997, a Transportable Selected Ion Flow Tube (TSIFT) instrument 
was constructed at Keele University with a short flow tube of about 40 cm long. Further 
developments have enabled construction of a compact SIFT-MS instrument, Profile 3, 
with flow tube of only 5 cm long, easily transportable with a weight of 120 kg.  
As already mentioned above, the SIFT-MS method is based on chemical 
ionization, in which the “soft” ionization of neutral molecules is achieved by selected 
species of reagent ions. This approach minimizes fragmentation of product ions of 
reactions and thus simplifies the analytical mass spectrum [250].The selection of the 
appropriate reagent is than an important step of the overall analytical process, whereas 
 
Optical viewing
port
Flow Tube
T2
Reactant gas
entry ports
Optical viewing
port
S2
Diffusion
 pump
S1
O1
L1
QMF
L2
T1
C
O3
pico-
ammeter
Diffusion
 pump
QMS CM
L3
Roots
 pump
O2
   
65 
reagent ions must be relatively unreactive with the major components of the air and breath 
sample, e.g. N2, O2, H2O, Ar and CO2 in comparison with the trace gases to be analyzed 
(10-1000 ppbv). Otherwise the reagent ions would be consumed immediately in the 
reactions with major gases [255]. The reagent ions involved in SIFT-MS ionization were 
therefore chosen on the basis of understanding of ion chemistry occurring in terrestrial 
atmosphere (see Figure 3.3) [256]. It has been established using rocket-borne and 
satellite-born mass spectrometers (upper atmospheric regions) that NO+ and O2+• ions are 
dominant in the thermosphere and that H3O+ (H2O)n are the dominant ions in the altitudes 
around 70 km. This is explained by low reactivity of H3O+, NO+ and O2+• with air 
molecules. Therefore, these ions are ideal as reagents for selective chemical ionisation of 
reactive compounds present in air matrix. It has been proved by subsequent research that 
the use of these reagents either separately or in combination is the real strength of SIFT-
MS [75]. 
 
Figure 3.3. The positive ion composition of atmosphere as a function of altitude. (Reproduced from 
Španěl et al., The Journal of Chemical Physics, 1996 [255]). 
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3.1.2.2.1 Profile 3 instrument 
 
Currently used, compact and transportable version of a SIFT-MS instrument, 
Profile 3, with flow tube of only 5 cm long and weight of 120 kg, has been first 
manufactured in 2006 by Instrument Science Limited. This instrument was also used in 
all experiments discussed in this work and is schematically described in Figure 3.4. 
 
 
 
Figure 3.4. Schematic diagram of the Profile 3 SIFT-MS instrument showing the microwave discharge 
ion source, injection mass filter and the detection quadrupole mass spectrometer and the three metal discs 
to which ion current can be measured and which support the orifices O1, O2 and O3 through which, 
respectively, ions pass from the ion source into the injection mass filter, mass selected ions enter the flow 
tube and via which ions are sampled into the analytical quadrupole mass spectrometer. Picture finally 
illustrates both sampling methods - direct breath sampling into the instrument and sampling from bag 
samples. (Reproduced from Smith et al., International Journal of Mass Spectrometry, 2009 [257]). 
 
Positive ions are generated in an electric discharge ion source (usually microwave 
glow discharge) from a mixture of water vapour and air [258] maintained at total pressure 
of 0.3 mbar. From the mixture of ion species extracted through the orifice O1 a current of 
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ions of a given mass-to-charge ratio, m/z, is obtained using a quadrupole mass filter. 
Selected precursor/reagent ions (H3O+, NO+ or O2+•) are then injected into a fast-flowing 
inert carrier gas (usually helium at a pressure of 100 Pa ~ 1 Torr) via the orifice O2 and 
convected along the flow tube (diameter of 1 cm and 5 cm long). Concurrently, the neutral 
analyte molecules of a sample vapour can be introduced into the flow tube (a continuous 
flow of the gas sample, typically 20 to 40 mL/min at standard atmospheric pressure and 
temperature) via a heated and calibrated sampling capillary. The actual flow rate can be 
measured by a mass flow meter connected to the sample inlet. The capillary and the 
connecting tubes (all made from polyether ether ketone (PEEK)) are all heated to about 
80ºC to prevent condensation of water and other condensable species and memory effect. 
The reagent ions finally meet the gas sample in the area of flow tube and may 
react - undergo chemical ionisation, depending on their chemical properties (proton 
affinity or ionisation energy). The reaction is allowed during a defined reaction time (0.6 
ms), which is determined by the carrier gas flow rate and the reaction length. The 
reactions of reagent ions with trace gases in the sample diluted by the carrier gas form the 
product ions that are characteristic of each trace gas compound. The product ions are 
finally analysed using the detection (analytical) quadrupole mass spectrometer and are 
counted by a channeltron multiplier/pulse counting system. Thus the obtained count rates 
are used in calculation of the concentrations of volatile compounds.  
The SIFT-MS instrument can be operated in two modes: The Full Scan (FS) mode 
or Multiple Ion Monitoring (MIM) mode [244]. In FS, a complete mass spectrum is 
obtained by sweeping the detection quadrupole over a selected m/z range for a chosen 
time whilst a sample of air or breath is introduced into the carrier gas at a steady flow 
rate. In the MIM mode, only the count rates of the reagent ions and those of selected 
product ions are monitored as function of time. This real-time monitoring is possible 
because of the fast time response of SIFT, approximately 20 ms. 
The software that controls the instrument allows switching of the injection mass 
filter between the selected m/z values of the reagent ions (19, 30 and 32). Worthy of note 
from the point of view of analytical sensitivity is the effective dwell time, td, during which 
the product ions of a given m/z are accumulated. In the FS mode the total measurement 
time, td, for each ion (m/z value) is: 
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𝑡𝑑 = 0.3
𝑛𝑠𝑡𝑠
(𝑚1 − 𝑚0)
 (3) 
Here, ns is the number of full scans, ts is time of each scan, m0 and m1 are limit m/z values 
of the scan. So, for example, for a single scan (ns=1) across the range m/z 10-130 with 
each scan lasting 60 s, the dwell time for a single product ion is 150 ms. Therefore, at 
least 7 such scans (whilst maintaining the sample flow for 7 minutes) would have to be 
integrated to achieve 1 s of integration time. Often it is practical to cycle the reagent ions 
between the individual full scans (e.g. m/z 19; then 30; then 32; and repeat ….) and obtain 
5 full scans for each reagent ion (15 scans total). In this way, representative mass spectra 
can be obtained even when the composition of the sample is slowly changing with time. 
In the MIM mode, which provides more precise quantification of the targeted trace 
compounds than does the FS mode, the total measurement time per product ion, tm, is 
related to the total sampling time, ti, the reagent and product ion dwell times, treag and 
tprod, the number of reagent and product ions recorded, nreag and nprod, the wait time before 
counting on each ion, tw, and the fly back time, tf, by the expression: 
 
𝑡𝑚 =
𝑡𝑖𝑡𝑝𝑟𝑜𝑑
[𝑛𝑟𝑒𝑎𝑔(𝑡𝑟𝑒𝑎𝑔 + 𝑡𝑤) + 𝑛𝑝𝑟𝑜𝑑(𝑡𝑝𝑟𝑜𝑑 + 𝑡𝑤) + 𝑡𝑓]
=
𝑡𝑖𝑡𝑝𝑟𝑜𝑑
𝑡𝑐𝑦𝑐𝑙𝑒
 (4) 
 
 
Here, tcycle is the time taken to collect the data for all ions, effectively giving the resolution 
of the time profiles along the x-axis.  
The available count rate of the reagent ions determines the sensitivity and 
precision of SIFT-MS analysis; 106 counts per second is a desired value. Reduction of 
this count rate by a factor of two results in the precision of the measurement to be lowered 
1.4 times (square root dependence). However, a reagent ion count rate that is too large 
can result in non-linearity of the ion detector (due to its dead time); this can be 
compensated for [259] and can be checked by the relative intensities of the 18O 
isotopologues of the H3O+ and O2+• reagent ions. 
 As mentioned above, the SIFT-MS method enables analysis by using three 
different precursor/reagent ions (H3O+, NO+ or O2+•). According to the selected reagent 
ion we finally speak about the H3O+, NO+ or O2+• reactions. 
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3.1.2.2.2 H3O+reactions 
 
The reactions between H3O+ reagent ions and organic molecules (M) proceed 
predominantly via proton transfer and usually result in only one characteristic (MH+) 
product ion. However, these MH+ ions sometimes dissociate to M-OH. This 
fragmentation results from elimination of water after protonation of some alcohols or 
larger aldehydes or carboxylic acids. The important point is that the proton affinity of the 
molecules must be greater than that of H2O for proton transfer to occur. The ion chemistry 
of the H3O+ reagent ion with many different compounds has been previously 
comprehensively described in the literature. 
Except of “primary” reactions are for H3O+ reagent ion characteristic also 
“secondary” reactions, because in the presence of water molecules the MH+ product ions 
can associate with H2O forming  hydrated ions MH+(H2O)1,2,3. The H3O+ reagent ions are 
also partially converted to hydrated hydronium ions H3O+(H2O)1,2,3, that can act as 
additional reagent ions, and contribute to the production of MH+(H2O)1,2,3 via ligand 
switching reactions [260,261]. Therefore, the ion chemistry, which is important for real 
time and accurate quantification, is influenced by the presence of water vapour and it is 
necessary to account for this. This topic will be covered in detail in the following chapter: 
4.2 Three-body association reactions – ion chemistry involving water molecules. 
 
3.1.2.2.3 NO+ reactions 
 
The reactions of NO+ are more diverse in comparison to those of H3O+, but usually 
also result in one or two primary product ions. Due to the low recombination energy (RE) 
of NO+ ions (9.25 eV) they cannot ionize the major air components. Thus, only molecules 
with ionization potential (IP) less than 9.25 eV can be ionized by charge transfer. Another 
reaction mechanisms characteristic for NO+ reagent ions are then  hydride ion transfer, 
producing (M-H)+ ions, and association reaction, producing NO+ M ions. NO+ is in 
practical SIFT-MS analyses mainly used to quantify aldehydes, ketones and carboxylic 
acids. The use of NO+ can in most cases help when minimising the effects of isobaric 
compounds. When using NO+ reagent ions to analyse humid samples, the role of water 
must be again accounted for, because a fraction of product ions can again associate with 
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H2O molecules forming hydrated ions [75,246]. See chapter 4.2 Three-body association 
reactions – ion chemistry involving water molecules for additional details. 
 
3.1.2.2.4 O2+• reactions 
 
For a radical cation, O2+•, a characteristic reaction with VOCs is dissociative 
charge transfer [258]. The resulting primary product ion is a radical cation. The charge 
transfer is usually dissociative with the fragmentation patterns similar to electron 
ionisation, EI. Similar fragmentation follows, usually favouring a closed shell ion 
product. Because the energy is well defined in the charge transfer (in contrast to the wide 
energy distribution in EI) there are fewer types of fragments. However, the spectra of 
VOCs obtained using the O2+• reagent ions are typically more complicated than those 
obtained using H3O+ or NO+. The choice of reagent ion depends on the compounds to be 
analysed, in the case of O2+• this is the reagent of choice for very small molecules 
including NH3 [262] and CH4 [263] or hydrocarbons like isoprene [264] or pentane. 
Different product ions are produced in the reactions with the different reagent ions. Such 
can be used in identification of isobaric compounds [75]. 
 
3.1.2.2.5 Absolute quantification 
 
The theoretical background for the absolute quantification of the trace gases in 
real time is based on the first order kinetics. In general, the absolute concentrations are 
calculated based on knowledge of the rate constants, reagent and product ion count rates 
and the known reaction time.  
As an illustrative example can be used the proton transfer reaction (only one 
compound, M, reacts with reagent ion to produce product ion, MH+). 
 
H3O+ + M → MH+ + H2O (5) 
 
the reaction proceeds during a well-defined reaction time tr (typically 0.6 ms) with the 
rate constant k. MH+ is assumed to be the only product ion and if [H3O+] >> [MH+], then 
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the kinetics can be approximated by the Equation 6 (note the [ ] brackets represent count 
rates): 
 [𝑀𝐻+] = 𝑘[𝑀][𝐻3𝑂
+]𝑡𝑟 (6) 
[M] can be finally expressed as: 
[𝑀] =
1
𝑡𝑟
[𝑀𝐻+]
𝑘[𝐻3𝑂+]
 (7) 
The measured ion signals are proportional to the ion concentrations. Therefore the 
measurement of the MH+/H3O+ signal ratio analysed by the mass spectrometer allow the 
absolute quantification of M. 
However, in some cases the reaction scheme is more complicated and involves 
ion clusters. Then the following general equation must be used to calculate the 
concentration of the trace gas molecule, [M]: 
[𝑀] =
1
𝑡𝑟
𝑓𝑝1𝐼𝑝1/𝐷𝑒𝑝1 + 𝑓𝑝2𝐼𝑝2/𝐷𝑒𝑝2 + ⋯
𝑓𝑖1𝐼𝑖1𝑘1 + 𝑓𝑖2𝐼𝑖2[(𝑘1 + 𝑘2)/2]/𝐷𝑒𝑖2 + ⋯
 (8) 
 
In the case of larger concentration of [M] and assumption of the secondary reactions of 
the product ions, Equation 8 should be expanded to the logarithmic form: 
[𝑀] =
1
𝑘1𝑡𝑟
ln (1 + 𝑘1
𝑓𝑝1𝐼𝑝1/𝐷𝑒𝑝1 + 𝑓𝑝2𝐼𝑝2/𝐷𝑒𝑝2 + ⋯
𝑓𝑖1𝐼𝑖1𝑘1 + 𝑓𝑖2𝐼𝑖2[(𝑘1 + 𝑘2)/2]/𝐷𝑒𝑖2 + ⋯
) (9) 
  
 Ip1, Ip2 etc. presents product ion signals (count rates are corrected for the detector 
dead time and for mass discrimination in the downstream quadrupole mass 
spectrometer [259]); 
  Ii1, Ii2 etc. are reagent ions signals (e.g. H3O+, H3O+(H2O), again corrected for 
mass discrimination and dead time); 
  k1,2 are rate constants of ion-molecular reactions between reagent ions and neutral 
molecule [M]; 
 Dep1, Dep2, Dei2 etc. are differential diffusion coefficients of ion products and 
reagent ions. 
 
The absolute concentration of [M] in the flow tube can be converted to the relative 
concentration of the molecule in the gas sample, pM/p0, from the direct consideration of 
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continuous flow dilution of the sampled air (flow rate, Φa) in to the carrier gas (flow rate, 
Φc): 
𝑝𝑀
𝑝0
=
[𝑀]𝑝0
𝑛0𝑝𝑔
𝑇𝑔
𝑇0
𝛷𝑐 + 𝛷𝑎
𝛷𝑎
 (10) 
 n0 is a physical constant - Loschmidt’s number (2.687 x 1019 cm-3). It is a reference 
value of concentration at standard atmospheric pressure, p0 = 760 Torr and 
temperature T0 = 273.15 K [259]; 
 pg is the flow tube pressure; 
 Tg is the flow tube temperature.  
 
The relative concentration pM/p0 is expressed in the units of ppbv by multiplying by 109. 
The SIFT-MS is thus allowing the calculation of concentrations of the trace 
amounts of VOCs by using the physical quantities as flow rate of a sample (Φa) and 
helium carrier gas, flow tube pressure (pg) and temperature (Tg) and reagent and product 
ion signals (c/s), Ii, Ip  (their ratio). All the calculations are done by the analytical software 
automatically and immediately during each analysis, by using the kinetics data entries 
(set of reagent ions and product ions together with the rate constants and factors, f), which 
are stored in the so-called kinetic library in the special format (Table 3.2). Factors (fi and 
fp) are simply used to multiply the acquired raw count rate of the ion. Usually, values of 
1.0 are used, but in some cases would such a simple calculation not provide valid results 
and values other than 1.0 should be used to account for all the circumstances (see chapter 
4.3 Construction and optimization of kinetics library). 
 
Table 3.2. Sample kinetics library entries describing straightforward calculations of 2-hexanone 
concentrations using the three reagent ions indicated. Rate constants (k) are given in units of cm3s-1. 
NOTE: Because of historical reasons, the format of SIFT kinetic library requires the use of term “precursor” 
for the reagent ion.  
compound(ion) 
number of precursors 
 
m/z k fi 
 
 
number of products 
 
m/z k fp 
2-hexanone(H3O+) 
 4 precursors 
   19 4.0e-9 1.0 
   37 3.05e-9 1.0 
   55 2.66e-9 1.0 
   73 2.44e-9 1.0 
 2 products 
   101 1.0 
   119 1.0 
2-hexanone(NO+) 
 3 precursors 
   30 3.0e-9 1.0 
   48 1e-9 1.0 
   66 1e-9 1.0 
 
 1 product 
   130 1.0 
 
2-hexanone (O2+) 
 2 precursors 
   32 3.1e-9 1.0 
   50 1e-9 1.0 
 
 
4 products 
   43 1.0 
   58 1.0 
   85 1.0 
   100 1.0 
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3.2 Extraction methods for pre-concentration of trace substances for 
GC/MS analysis 
3.2.1 Solid-phase microextraction 
As already mentioned above, solid-phase microextraction (SPME) is one of the 
most frequently used methods for sample preparation in the area of breath analysis and in 
connection with GC-MS. This technique has been developed in the late 1980s by Arthur 
and Pawliszyn [265, 266] and is considered as a convenient, universal, rapid, inexpensive, 
and efficient technique for sampling solid, liquid, or gaseous samples. It requires no 
solvents or complicated apparatus and provides linear results over a wide range of analyte 
concentrations. Analysis of the extracts can be performed not only by using GC or 
GC/MS, but it can be also performed by High-performance liquid chromatography 
(HPLC) [85,267-269]. This technique was successfully used for the determination of 
volatile compounds from environmental, toxicological, and pharmacological specimens 
with different matrices. SPME has been also applied to analysis of VOCs in human breath 
[270]. 
In the SPME technique, a fused silica fiber coated with a polymeric stationary 
phase is contained in a specially designed syringe whose needle protects the fiber when 
septa are pierced. The fiber is directly exposed to a liquid or gaseous sample to extract 
and concentrate the analytes. After the equilibration of the sorption process is attained, 
the fiber is withdrawn into the needle and introduce into an injector of a gas 
chromatograph, where the extracted compounds are thermally desorbed and analysed. 
SPME can be performed manually or by an autosampler. The method is economical, 
because one single fiber can be used repeatedly. Unlike in conventional methods for 
analysis of gaseous samples, modified equipment like a complex valve injection system, 
a thermal desorption device, or a cooling trap is not required by SPME. The SPME fiber 
is easily cleaned by desorbing any contaminants in a hot GC injector. The SPME 
technique coupled with GC has been used to analyze volatile and semivolatile air 
compounds [271]. The fiber can be exposed directly to the air or to a sample collected in 
a gas sampling container.  
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Figure 3.5. Commercial SPME device made by Supelco. (Reproduced from Kataoka et al., Journal of 
Chromatography A, 2000 [272]). 
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3.2.2 Thermal desorption 
Analytical thermal desorption, known within the analytical chemistry community 
simply as thermal desorption (TD) is a versatile technique that concentrates volatile and 
semi-volatile organic compounds (VOCs and SVOCs) in gas streams prior to injection to 
gas chromatograph (GC). By extracting organic vapours from a sample and concentrating 
them into a very small volume of carrier gas, TD maximises sensitivity for trace-level 
target compounds, helps to minimise interferences, and routinely allows analyte detection 
at the ppbv concentration or below [273].  
This method originated in the mid-1970s as an adaptation to the injection 
procedure for GC. Injector liners were packed with a compound able to adsorb organic 
compounds, used to sample air or gas, and then dropped into the inlet of the GC. This 
principle was first widely employed for occupational monitoring, in the form of personal 
badge-type monitors containing a removable charcoal strip [274]. Such monitors offered 
the advantage of being amenable to analysis without a separate solvent-extraction step. 
In the 1970s was also developed a method by which volatiles in the air were collected by 
diffusion onto tubes packed with a sorbent, which was then heated to release the volatiles 
into the GC system. These were first introduced for monitoring sulfur and nitrogen 
dioxide [275] but the analyte scope later widened as the sorbents became more advanced. 
Another early method (closely related to the modern purge-and-trap procedure) involved 
passing a stream of gas through a water sample to release the volatiles, which were again 
collected on a sorbent-packed tube [276]. Such axial-type samplers, which later became 
known as 'sorbent tubes', were laid out as an industry standard in the late 1970s, by 
Working Group 5 (WG5) of the UK Health & Safety's Committee on Analytical 
Requirements (HSE CAR). At the same time, various basic functionality requirements 
for thermal desorption have been specified by the same group, and in the years since then, 
a number of improvements have been made to instrumentation for thermal desorption, 
including two-stage operation, splitting and re-collection of samples, improved trap-
cooling technology, standard system checks, and automation. 
Thermal desorption fundamentally involves collecting volatile organic 
compounds onto a sorbent, and then heating this sorbent in a flow of gas to release the 
compounds and concentrate them into a smaller volume. Early thermal desorbers used 
just single-stage operation, whereby the volatiles collected on a sorbent tube were 
released by heating the tube in a flow of gas, from where they passed directly into the 
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GC. Modern thermal desorbers can also accommodate two-stage operation, whereby the 
gas stream from the sorbent tube (typically 100–200 mL) is collected on a narrower tube 
integral to the thermal desorber, called the focusing trap or a cold trap. Heating this trap 
releases the analytes once again, but this time in an even smaller volume of gas (typically 
100–200 µL), resulting in improved sensitivity and better GC peak shape [269]. Modern 
thermal desorbers can accommodate both single-stage and two-stage operation, although 
single-stage operation is now usually carried out using the focusing trap to collect the 
analytes, rather than a sorbent tube. It is normal for the focusing trap to be held at or 
below room temperature, although a temperature no lower than 0 °C is sufficient for all 
but the most volatile analytes. Higher trap temperatures also reduce the amount of water 
condensing inside the trap (when transferred to the GC column, water can reduce the 
quality of the chromatography). 
The sorbent tube and the focusing trap may be packed with one or more sorbents. 
The type and number of sorbents depends on a number of factors including the sampling 
setup, the analyte volatility range, analyte concentration, and the humidity of the sample 
[277,278]. One of the most versatile and popular sorbents for thermal desorption is 
poly(2,6-diphenyl-p-phenylene oxide), known by its trademark Tenax®.[279] 
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4 Results and Discussion 
The section “Results and Discussion” is divided in five subsections that 
summarize or complement published work that I have worked on during my PhD study. 
Each subsection thus represents comments on peer reviewed journals included in my 
dissertation, having the objectives, methods, results and discussion and conclusions.  
 
4.1 Determination of rate constants and product ion branching ratios 
Objectives 
It is a generally accepted fact that before proceeding to deeper investigation in the 
area of SIFT-MS analysis, the relevant knowledge of ion chemistry for compounds of 
interest are necessary.  Therefore the first subsection of my thesis is focused on the details 
of studies (carried out during the PhD project) concerning the ion chemistry and overview 
of the whole experimental process, starting from observed mass spectra and leading to 
determination of the rate constants. In summary, the step by step activities conducted on 
the beginning of each project.  
The data presented in this subsection will relate to the research articles published 
in impacted peer reviewed journals, as included in the Appendices A [280] and B [165] 
dealing with a group of carboxylic acids and a group of possible IBD biomarkers.  The 
chapter is not only summarising the published work, but also provides some additional 
details. At the onset, it is nevertheless useful to outline the motivation for the choice of 
compounds: 
 
A selected ion flow tube study of the ion molecule association reactions of protonated 
(MH+), nitrosonated (MNO+) and dehydroxidated (M-OH)+ carboxylic acids (M) with 
H2O (see Appendix A) 
The ion chemistry study has been carried out of the reactions of H3O+, NO+ and 
O2+• with four carboxylic acids, namely formic acid, acetic acid, propionic acid and 
butyric acid. Carboxylic acids are VOCs important in many areas of research: from the 
medical diagnostics and therapeutic monitoring, where the carboxylic acids are used for 
diagnostics of oral malodour [281,282], esophago-gastric cancer [142-144] or severe 
asthma [283], to food science [284], where is SIFT-MS analysis of these compounds used 
   
 78 
for monitoring of biochemical reactions [285], but mainly for quality assessment (in this 
content analysis of food aromas) [286-287].  
 
SIFT-MS quantification of several breath biomarkers of inflammatory bowel disease, 
IBD: a detailed study of the ion chemistry (see Appendix B) 
This work was focused on several compounds (2-methylpentan, 1,3,5-triazine, trans-2-
octene, cis-2-nonen-1-ol, 2´-methylacetophenone, 1-heptene and 2-hexanone) previously 
identified to be present in modified concentrations in the breath of patients with inflammatory 
bowel diseases, IBD. For additional details regarding this illness and background concerning 
investigation in this area see chapter 2.3.3 Inflammatory bowel disease. A selected ion flow 
tube, SIFT, of the reactions of H3O+, NO+ and O2+• with these volatile organic compounds 
has been carried out with the ultimate goal to obtain the rate constants and product ion 
branching ratios of the primary reactions including three-body association rate constants, 
describing the rate of hydration (see the next chapter 4.2 Three-body association 
reactions). The results of this study allow accurate SIFT-MS quantification of these 
compounds in exhaled breath via the non-invasive way. 
 
Methods 
Determination of branching ratios 
In order to determine the product ions and their branching ratios, mixtures of dry 
air/ambient air and a trace amount (less than 10 parts per million by volume, ppmv) of 
vapour of a compound were introduced into the SIFT instrument (Profile 3 SIFT-MS 
manufactured by Instrument Science Limited, Crewe, UK) via a heated calibrated 
capillary and full scan (60 s integration time) mass spectra were acquired whilst each of 
the three selected reagent ions were alternately injected into the helium carrier gas. Note 
that switching between the three reagent ions H3O+, NO+ and O2+• was controlled 
electronically by the data system. The m/z mass spectral range (typically m/z 10-200) was 
chosen on the basis of the molecular weights of compounds included in the study, 
allowing for possible formation of adduct ions (hydrated ions – additional details are 
available in the chapter 4.2 Three-body association reactions – ion chemistry involving 
water molecules). The major ion products were identified by inspection of these mass 
spectra (see Figure 4.1  as example of SIFT-MS spectra obtained for 1-heptene; m/z 57 
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and 99 have been identified as major product ions when the H3O+ reagent ion has been 
used; m/z 86, 100, 104, 118, 128, 146 by utilising NO+ reagent ion and  m/z 56, 69, 70 
and 98 for O2+• reagent ion) and their count rates were precisely determined in separate 
experiments using the multi-ion monitoring (MIM) mode [47].   
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Figure 4.1. The SIFT-MS spectrum obtained for 1-heptene. The arrows indicate the ions resulting from 
the reactions of the H3O+ reagent ion (A); NO+ reagent ion (B) and O2+•  reagent ion (C). 
 
When looking at the Figure 4.1 – C, it is worthy to mention again, that the SIFT-
MS spectrum has the fragmentation patterns similar to MS spectrum gathered by electron 
ionisation (see the Figure 4.2 illustrating the mass spectrum gathered for 1-hepten).  
 
 
Figure 4.2. The EI mass spectrum for 1-heptene. The spectrum has been obtained from the NIST MS 
Search 2.0 library. 
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In the MIM mode, the appropriate reagent ion and all the identified product ions 
were included. In case of the study focused on carboxylic acids, the variable 
concentrations required for the experiment were achieved by gradually adding vapour of 
a compound of interest to the Nalophan bag with dry air by a syringe, whereas in case of 
IBD possible biomarkers study, the dependence of ion count rates on the changing amount 
of the molecules of the VOC/air mixture flowing into the He carrier gas was obtained by 
varying the flow rate of the sample (see the example of 1-heptene data in Figure 4.3). 
Flow rate of the injected gaseous sample was than varied by a needle valve and monitored 
by a flow meter (manufactured by Voegtlin, Aesch, Switzerland).  
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Figure 4.3. The time profile of the decay of signal in c/s of the 1-heptene product ions together with 
reagent ions - H3O+ (A); NO+ (B) and O2+• (C).  As can be seen from these time profiles, to avoid omitting 
of any possible product ions, usually more interesting m/z have been investigated than finally confirmed 
(f.e. m/z 119 in case of H3O+ reagent ion or m/z 72 in case of NO+ reagent ion). 
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The primary product branching ratios of the reactions were then determined by 
plotting the percentages of the individual product ions on a linear scale as a function of 
the sample mixture flow rate determined accordingly to the exponential reduction of the 
reagent ion count rate. The example of this type of a plot for 1-heptene is shown in Figure 
4.4. By extrapolating to zero sample gas/vapour flow (i.e., estimating the limit at zero 
sample concentration) the true primary branching ratios, excluding any secondary 
reactions were obtained. In our experiments, only product ions with resulting branching 
ratio greater than 5% were reported. 
 
Figure 4.4. A plot of percentages of individual product ions as a function of the flow rate of a mixture 
containing heptene in humid air introduced into SIFT when NO+ reagent ions are injected. The 
primary product branching ratios are obtained by extrapolating the lines to zero flow. 
 
Determination of the rate constants 
SIFT-MS quantification requires knowledge of rate constants, which can be 
obtained either from original papers, eventually from the Anicich index of the literature 
for bimolecular gas phase cation-molecule reaction kinetics [288]. Nevertheless, in some 
cases the required rate constant may not available and then must be determined 
experimentally by the following procedure, that has been utilised for example in case of 
work focused on IBD possible biomarkers.  
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It is well established that proton transfer reactions of H3O+ proceed at collisional 
rate when these reactions are exothermic by more than 40 kJ/mol [289]. Thus, the rate 
constants (k) for the reactions of H3O+ can be calculated as collisional (kc) according to 
using the Su and Chesnavich parameterized trajectory theory [290] using the dipole 
moments (μr) calculated according to the density functional theory (DFT, B3LYP, 6-
31G*) using Abalone software (NWChem, version 1.8.88, Agile Molecule) and 
polarisabilities (α) calculated according to empirical method from the chemical structure 
of the molecules [291]. The example of the dipole moment calculation result by using the 
Abalone software is available in the Figure 4.5.  First of all, it is necessary to draw 
properly the molecule of interest. In the following step the geometry must be optimised 
by the selected method (in our case DFT/b3lyp/6-31G*). Finally, the software provide 
information about the dipole moment (tab „electrostatics“).  
 
Figure 4.5. Print screen from the Abalone software – calculation of dipole moment by the DFT/b3lyp/6-
31G* method. 
 
The rate constants for the reactions with NO+ and O2+• (k) are then determined based 
on their experimentally derived decay rates relatively to that for the H3O+ reaction by 
injecting all three reagent ions simultaneously and allowing them to react with the neat 
vapours of the compounds introduced at varied concentrations [257]. In these 
experiments, SIFT-MS instrument (still in the MIM mode) is set up to allow all three 
reagent ions to react simultaneously with the product ions (Figure 4.6). This can be 
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achieved by adjusting the mass setting of the injection mass filter to zero value effectively 
setting the voltage differential between the quadrupole rods to 0 V. The flow rate of 
injected sample is again controlled by opening and closing the needle valve and is 
monitored by a flow-meter. The maximum flow rate in our experiments was 33.4 mL/min 
at standard atmospheric pressure and temperature, whereas the minimum flow rate was 0 
mL/min. Uncertainty in the absolute value of the determined rate coefficients is +/-20% 
[47]. 
 
 
Figure 4.6. MIM profile when all three reagent ions are injected simultaneously into the flow tube 
where they react with the sample (1-heptene) introduced at varied concentration.  
 
The plot of experimental dependence of the reagent ion count rates on the sample 
flow rate is shown in Figure 4.7. The slope reflects the experimental derived relative rate 
constant which is then multiplied by the theoretically calculated value of kc of H3O+ in 
order to obtain absolute values for the NO+ and O2+• reactions. 
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Figure 4.7. The count rates of H3O+, NO+ and O2+• plotted on a semi-logarithmic scale as functions of 
the sample flow rate for 1-heptene. The rate constants (k) for the NO+ and O2+• reactions are finally 
determined from the relative slopes of these plots. 
 
Results and Discussion 
In this part, the results gathered within the experiments focused on carboxylic 
acids and IBD possible biomarkers are summarized and presented. Not only data 
published in the relevant manuscripts (Appendices A and B), but also results not explicitly 
included in these works - predominantly, examples of individual mass spectra of IBD 
possible biomarkers are presented in this section, because these are new and original data. 
In the following text the product ions resulting from the ion-molecule reactions are 
discussed.  
 
1. Carboxylic acids 
Product branching ratios for the primary H3O+, NO+ and O2+• reactions 
Primary product ions and the corresponding branching ratios observed in the 
experiments are summarized and available in form of a table in the relevant manuscript 
(Appendix A). 
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In general, the main primary product for all the H3O+ reactions is the protonated 
parent molecule, MH+.  In the case of formic acid and acetic acid we are speaking about 
the only primary ionic product. On the contrary, in case of propionic acid and butyric acid 
reactions, there are two primary product ions - the protonated parent molecule, MH+, and 
the molecular ion which is created through the way of water molecule lost from the 
protonated parent molecule. The data obtained within this study are in agreement to those 
previously published [292].  
The reactions of NO+ with the carboxylic acids proceed via three-body association 
reactions forming M·NO+ adduct ions or via hydroxide ion transfer. It is important to 
highlight, that reactions of formic acid and acetic acid are in comparison to the collisional 
rate constant significantly slower and the only product is the M·NO+ adduct ion. This fact 
can be explained by the lack of any available exothermic bimolecular reaction channels. 
The higher carboxylic acid, such as propionic or butyric acid, proceed via both reaction 
paths, three-body association reaction and hydroxide ion transfer, nevertheless, the adduct 
ion is always the major product (see the attached manuscript – Appendix A for additional 
details).  
The reactions of carboxylic acids with O2+• reagent ions are (with the exception of 
the reaction of formic acid, which has proven to be slower than previously anticipated) 
fast with no obvious trends within the ionic products. The most frequent reaction pathway 
is the non-dissociative charge transfer reaction, producing the parent radical cation M+•. 
The other common reactions pathway is also dissociative charge transfer resulting in 
several fragment ions.  
 
Rate constants for the primary H3O+, NO+ and O2+• reactions 
The calculated rate constants (kc) for H3O+ reactions and the rate constants (k) for 
the NO+ and O2+• reactions are available in the relevant manuscript and are in compliance 
with the previously published values [292]. More accurate rate constants for the primary 
NO+ and O2+• reactions of formic acid were obtained in our experiment, where we 
compared the product ion count rates in the H3O+, NO+ and O2+• reactions. We have found, 
that both reactions were slower than the previously published upper limits of 
0.1x10-9cm3s-1 and 2x10-9cm3s-1 respectively [292]. The rate constant for reaction with 
H3O+ reagent ion was thus estimated as 0.05x10−9 cm3 s−1 and the rate constant for 
reaction with O2+• reagent ion as 0.4x10−9 cm3 s−1.  
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2. IBD possible biomarkers 
Product branching ratios for the primary H3O+, NO+ and O2+• reactions 
Same as in the case of carboxylic acids, primary product ions and the 
corresponding branching ratios observed in the experiments are summarized in the form 
of a table, which is available in the relevant manuscript (Appendix B). 
The major ion product of the H3O+ reactions with most of the investigated IBD 
possible biomarkers is again the protonated molecule, MH+, whereas minor channels 
involving fragmentation are also evident. Nevertheless, in some cases the protonated 
molecule has not been observed at all.  
The first exception is the reaction of 2-methylpentane, where two parallel reaction 
channels are observed: the three-body association, that is possible because the proton 
transfer reaction is endothermic [293] and the channel that corresponds to a loss of a H2 
from the protonated molecule): 
 
H3O+ + CH3CH2CH2CH(CH3)2  → CH3CH2CH2CH(CH3)2H+H2O  (11a) 
 → CH3CH2CH2CHCH3CH2++H2+H2O (11b) 
 
The second reaction channel described by the Equation 11b is not a reaction commonly 
observed in SIFT-MS studies. Based on this fact, reaction enthalpy has been calculated 
to determine if the reaction is exothermic. Using the data from [294], it was finally 
confirmed, that the product is energetically possible, as the reaction enthalpy, ∆𝑟𝐻𝑇
∅ , is -
66 kJ/mol.  
The second exception is than reaction of cis-2-nonen-1-ol, where the reaction 
proceed only via dissociative proton transfer – the reaction channel common for larger 
alcohols, resulting in production of the hydrocarbon fragment ions, M-H2O+.  
 
H3O+ + CH3(CH2)5CH=CHCH2OH → CH3(CH2)5CH=CHCH2++ 2 H2O  (12) 
 
In the terms of primary product attractiveness, 1,3,5-triazine is very interesting 
compound, as the protonated parent molecule has even mass, which is not very common  
and can be easily recognized on SIFT-MS spectra as a signature for nitrogen containing 
compounds. The individual mass spectra of IBD possible biomarkers are available in 
Figures 4.8 a-e.  
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In case of some investigated IBD possible biomarkers, formation of the hydrated 
protonated molecules resulting from the secondary reactions with water present in the 
reactant mixture has been observed. For additional details see the next chapter (4.2 Three-
body association reactions).  
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Figure 4.8 a)-e). The SIFT-MS spectra obtained when the headspace above a) 2-methylpentane, b) s-
triazine, c) trans-2-octene, d) cis-2-nonen-1-ol and e) 2-methylacetophenone has been sampled. The 
arrows indicate the ions resulting from the reactions of the H3O+ reagent ion. The SIFT-MS spectrum for 
1-heptene is not included, as it was presented in the introduction of this chapter (see above). The SIFT-MS 
spectrum is not included, as it was presented in earlier studies. 
 
The ion products of the NO+ reactions with some IBD possible biomarkers are 
shown in the mass spectra in Figures 4.9 a-f. The reactions of NO+ with the IBD possible 
biomarkers proceed via three-body association, forming MNO+ adduct ions, via hydride 
ion, H-, transfer, or via charge transfer producing nascent M+ ions. The hydration of the 
primary products by the association reactions with H2O present in the reactant mixture is 
again quite common and is described in detail in the chapter below (4.2 Three-body 
association reactions).
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4.9 a)-f). The SIFT-MS spectra obtained when the headspace above a) 2-methylpentane, b) s-triazine, c) trans-2-octene, d) cis-2-nonen-1-ol, e) 2-methylacetophenone 
and 2-hexanone has been sampled. The arrows indicate the ions resulting from the reactions of the NO+ reagent ion. The SIFT-MS spectrum for 1-heptene is not included, as 
it was presented in the introduction of this chapter (see above)
   
 92 
Majority of the reactions of IBD potential biomarkers with O2+• reagent ions 
proceed via charge transfer producing the parent radical cation M+•. Another common 
reaction pathway is the dissociative charge transfer resulting in several fragment ions, 
which are very often radicals. The spectra obtained using the O2+• are in comparison to 
those gathered by using H3O+ or NO+ more complicated (see Figure 4.10 a-c). The 
observed fragment are also formed by electron ionisation which proceeds via a similar 
mechanism involving transient molecular radical cation. 
Figure 4.10 a)-c). The SIFT-MS spectra obtained when the headspace above a) s-triazine, b) cis-2-
nonen-1-ol and c) 2-methylacetophenone has been sampled. The arrows indicate the ions resulting from 
the reactions of the O2+ reagent ion.  
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For additional details regarding the product branching ratios for the primary H3O+, 
NO+ and O2+• reactions see the relevant manuscript (Appendix B). 
 
Rate constants for the primary H3O+, NO+ and O2+• reactions 
The calculated collisional rate constants (kc) and the experimentally derived rate 
constants (k) are available in the tabulated form in the relevant manuscript (Appendix B). 
In general, all the H3O+ reactions are assumed to proceed at the collisional rate for all the 
investigated molecules with only one exception: 2-methylpentane. This compound does 
not have a sufficiently high proton affinity and therefore it reacts at faster rate with both, 
NO+ and O2+• reagent ions. Such a slow reactions have been previously observed also for 
other saturated hydrocarbons, including hexane and octane [295].  
Regarding the NO+ and O2+• reactions with IBD possible biomarkers, most of 
them also proceed near to collisional rate. The exception is in this case cis-2-nonen-1-ol 
for which only very slow reactions are observed. 
 
Conclusions 
The ion chemistry studies discussed in this section provided some new data for 
the kinetics of the reactions important for SIFT-MS quantification of biogenic volatile 
organic compounds in air, and these data can be included in the kinetics library used for 
automated immediate quantification. However, in case of SIFT-MS, we have to take into 
consideration many minor challenges, which can influence the gathered results. Although 
we are talking about the effect of possible overlaps of product ions from different 
compounds at the same m/z, or impurities of the utilised sampling containers. All these 
possible issues are discussed in the following chapters, Section 4.3 Construction and 
optimization of kinetics library and Section 4.5 Challenges in connection with breath 
analysis - Nalophan sampling bags. 
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4.2 Three-body association reactions – ion chemistry involving water 
molecules 
Objectives 
In the case of breath analysis, we are usually working with samples influenced by 
the presence of water vapour. Therefore it is necessary to take into consideration also the 
secondary association reactions of primary product ions with water molecules inevitably 
present in biological samples. The understanding of these reactions is necessary for 
comprehensive and full understanding of the ion chemistry, to be used for accurate 
quantification by SIFT-MS.  
The three-body associations were again the subject of the research articles 
concerning carboxylic acids, Appendix A [280] and the possible IBD biomarkers, 
Appendix B [165]. In the case of article focused on carboxylic acids, the connection with 
secondary association reactions is noticeable already from the title of this study and the 
main topic of this work were predominantly the secondary association reactions of the 
primary product ions with water molecules. In case of article focused on the IBD possible 
biomarkers, the secondary association reactions were again investigated in order to 
achieve overall knowledge of the ion chemistry. 
Experimental methods 
The three-body association rate constants were determined for protonated 
molecules formed in the H3O+ reactions with the molecules M and for products formed 
in the NO+ primary reactions. 
Reactions of protonated molecules MH+ with H2O 
As already partly outlined in the theoretical part of this thesis, in the presence of water 
the association reactions of proton transfer product ions MH+ with H2O are common, 
forming MH+(H2O)1,2,3. Moreover, the H3O+ reagent ions are in part converted to hydrated 
hydronium ions H3O+ (H2O)1,2,3 and these cluster ions can act as additional reagent ions 
and produce further ion products like MH+(H2O)1,2,3 via ligand switching reactions. In 
SIFT-MS measurements using the H3O+ reagent ions both, MH+ and its hydrates 
MH+(H2O)1,2,3  are usually formed and the ratio of the count rates of these ions is a 
function of the sample flow rate and the sample humidity. The efficiency of clustering as 
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a fundamental parameter related to the three body rate constants can be finally determined 
by recording the above mentioned relative count rates. 
Three-body rate constants for the association reactions of MH+ ions with H2O 
molecules in helium, 𝑘𝑀𝐻+ describe the rate of hydration of the protonated molecules in 
the gas phase: 
 
MH+ + H2O + He → MH+(H2O) + He           (13) 
 
In order to obtain these rate constants experimentally it is important to account for the 
contribution of the ligand switching reactions of the H3O+(H2O) ions formed in the 
following three-body reaction described by the rate constant 𝑘𝐻3𝑂+: 
 
H3O+ + H2O + He → H3O+(H2O) + He           (14) 
 
The three-body rate constant for reaction (14) has been previously determined to be 
 𝑘𝐻3𝑂+= 6 × 10
−28 cm6 s−1 [261]. The cluster ions formed in reaction (14) contribute to the 
formation of MH+(H2O) ions via ligand switching with M: 
 
H3O+(H2O) + M → MH+(H2O) + H2O            (15) 
 
The hydrated protonated molecules MH+(H2O) can thus be produced by two parallel 
routes reactions (13) and (15). The individual contribution of reaction (15) can be 
quantified by a parameter Seff representing the contribution of the switching reactions to 
their formation taken relatively to the total formation of hydrated hydronium ions: 
 
            𝑆𝑒𝑓𝑓 =
ln (([𝑀𝐻+]+[𝑀𝐻+(𝐻2𝑂)1,2,3]𝑠)/
[𝑀𝐻+])
𝑙𝑛([𝐻3𝑂+]0/[𝐻3𝑂+])
                                                           (16) 
 
Here, [MH+] and [H3O+] are the count rates of MH+ and H3O+ ions detected by the 
downstream mass spectrometer, assumed to be proportional to the concentrations of the 
ions at the end of the flow tube. [H3O+]0 is the count rate observed in the absence of water 
vapour, which is also equivalent to the sum of count rates of H3O+(H2O)0,1,2,3. The 
subscript s denotes the theoretical count rates of the MH+(H2O)1,2,3 ions formed in 
switching reactions only, as calculated from the linearised kinetic equation [261]: 
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          [𝑀𝐻+(𝐻2𝑂)1,2,3]𝑠 =
[𝑀]𝑡 ([37]
𝑘37
2
+ [55]
𝑘55
2
+ [73]
𝑘73
2
)                    (17)           
 
where t  is reaction time, k37, k55 and k73 are the rate constants for the switching reactions 
of the respective hydrated hydronium ions with M and [37], [55], and [73] are the actual 
count rates of the H3O+(H2O)1,2,3 ions as observed in the experiments. The divisors 2 in 
Eq. (17) describe the fact that due to their continuous formation in the flow tube [261], 
reaction times of the H3O+(H2O)1,2,3 ions are approximately half the reaction time of H3O+. 
The total contribution of both parallel routes of formation of the protonated hydrated ions 
via the association reaction (13) and via the switching reaction (15) can be described by 
a coefficient Aeff: 
            𝐴𝑒𝑓𝑓 =
2 ln (([𝑀𝐻+] + [𝑀𝐻+(𝐻2𝑂)1,2,3]𝐴) /(
[𝑀𝐻+]))
𝑙𝑛([𝐻3𝑂+]0/[𝐻3𝑂+])
                      (18)              
 
The factor 2 in Eq. (18) is again related to the mean reaction time available for the 
continuously formed MH+ ions, which is half of that available for the injected H3O+ ions. 
The net contribution of association without switching is then simply described as Aeff −Seff 
and the value of three-body association rate constant can be calculated as: 
 
            𝑘𝑀𝐻+ = (𝐴𝑒𝑓𝑓 − 𝑆𝑒𝑓𝑓)  ∙ 𝑘𝐻3𝑂+                                                                      (19)              
 
𝑘𝑀𝐻+ obtained from Eq. (19) is thus a fundamental three-body association rate constant 
anchored to the known value of 𝑘𝐻3𝑂+.  
 
Reactions of the primary products of NO+ reactions with H2O  
 
When using NO+ reagent ions to analyse humid samples, a fraction of product ions also 
associate with H2O molecules forming hydrated ions [75,246]. Ion products of the kind 
[M+NO]+ can be also formed via ligand switching reactions of NO+(H2O)1,2 [296]. The 
primary reactions of NO+ reagent ions with carboxyl acids and group of possible IBD 
biomarkers, M, result in the formation of various types of product ions (for example 
[M+NO]+, [M-OH]+ or [M-H]+ ions). In the presence of water molecules some of these 
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product ions associate with H2O molecules to form the adduct ions. Three-body rate 
constants for the association reactions of these ions with H2O molecules in helium, 𝑘𝐴+, 
describe the rate of hydration of these product ions in the gas phase. The process of 
formation of relevant hydrates can be described by a coefficient Aeff in analogy to the 
chemistry of the protonated molecules. Aeff that describes how much faster clustering of 
a given ion is compared to clustering of H3O+, can be obtained from experimental data by 
relating the conversion rate of primary product to their hydrates to the conversion rate of 
NO+ to its hydrates: 
 
𝐴𝑒𝑓𝑓 =
2 ln ([𝐴+]0/[𝐴
+])
𝑙𝑛([𝐻3𝑂+]0/[𝐻3𝑂+])
                                                                              
                                                              
=
2 ln ([𝐴+]0/[𝐴
+])
(𝑘𝐻3𝑂+/𝑘𝑁𝑂+)𝑘𝐻3𝑂+𝑙𝑛([𝑁𝑂
+]0/[𝑁𝑂+])
   (20)              
 
The ratio (𝑘𝐻3𝑂+/𝑘𝑁𝑂+) is used here to relate the association reaction of H3O
+ with H2O 
(rate constant, 𝑘𝐻3𝑂+) to the significantly slower association reaction of NO
+ with H2O 
(rate constant, 𝑘𝑁𝑂+). The subscript 0 again indicates the respective ion count rate in the 
absence of water vapour in the helium carrier gas. The value of the three-body association 
rate constant can be calculated as: 
 
 𝑘𝐴+ = 𝐴𝑒𝑓𝑓  
𝑘𝐻3𝑂+
𝑘𝑁𝑂+
𝑘𝑁𝑂+ = 𝐴𝑒𝑓𝑓  ∙ 𝑘𝐻3𝑂+                                   (21)              
 
 𝑘𝐴+ obtained from Eq. (21) is again a fundamental three-body association rate constant 
anchored to the known values of 𝑘𝐻3𝑂+(6.0×10−
28 cm6 s−1) [261,297] and 𝑘𝑁𝑂+ 
(5.0×10−29 cm6 s−1) determined experimentally.  
 
In order to investigate the secondary reactions, sample mixture with dry air and 
varying amounts of water has been tested for all the compounds of interest by using the 
Nalophan sampling bags. The humidity change has been achieved by two different ways 
in two separate experiments. In the first one, presence of water in the sample varied from 
the low humidity (approximately 0.5%), achieved by the mixture of dry air and 
investigated sample, over the standard laboratory value (usually 1.2%, mixture of 
laboratory air and investigated sample), to the concentration common for the exhaled 
breath (5-9%, mixture of exhaled breath and investigated sample). In the following 
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experiment, the humidity of the sample has been affected by the temperature change – a 
parameter having direct influence on the presence of water vapour in the sample. The 
humidity within this experiment moved around 5.5% at 37°C to 0.8% at 0°C. For both 
these investigations, the multi-ion monitoring (MIM) mode [47] has been utilized.  
 
Results and Discussion 
This Section presents results, which were included in the manuscripts in 
Appendices A and B. However, the additional details and data gathered in the scope of 
experiments conducted for the relevant topics were added.   
 
1. Carboxylic acids  
 
Formation of the hydrated protonated molecules resulting from the secondary 
reactions with water has been observed for all the carboxylic acids. For the entire 
investigated series are under experiment conditions characteristic not only primary, but 
also secondary hydrates. The rate constants of the three-body association reactions 
calculated using Equations (16) - (19) are given in the Table 4.5.   The source data for 
these calculations have been gathered by utilisation of MIM mode. 
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Table 4.5. Kinetic data for formation of hydrates of primary products of NO+ and H3O+ reactions with carboxylic acids. 
Compound Formula Kinetic data for formation of hydrates of primary 
products of  H3O+ reactions 
Kinetic data for formation of hydrates 
of primary products of  NO+ reactions 
Reaction Seffa Aeffb 𝑘𝑀𝐻+
c Reaction Aeffd 𝑘𝐴+
e  
Formic acid HCOOH [MH]++ H2O + He 0.43  2.76 1.40 [M+NO]++ H2O + He 2.88 1.73 
Acetic Acid CH3COOH [MH]++ H2O + He 0.43 4.50 2.44 [M+NO]++ H2O + He 1.83 1.10 
Propionic Acid C2H5COOH [MH]++ H2O + He 0.42 6.81 3.83 [M+NO]++ H2O + He 
[M-OH]+ + H2O + He 
0.17 
3.41 
0.15 
2.05 
Butyric Acid C3H7COOH [MH]++ H2O + He 0.41 8.64 4.93 [M+NO]++ H2O + He 1.13 0.68 
 
a Ligand switching efficiencies calculated from Eq. (16). 
bAssociation efficiencies obtained from experimental data using Eq. (18). 
cThree-body association rate constants calculated from Eq. (19). [10−28 cm6 s−1]  
dAssociation efficiencies obtained from experimental data using Eq. (20). 
eThree-body association rate constants calculated from Eq. (21). [10-27cm6s-1] 
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The example of the time profile obtained using SIFT-MS in the MIM mode, 
illustrating the humidity change as a function of temperature, is available below (Figure 
4.11). Already from this picture it is clear, that efficacy of the secondary hydrates 
formation is not negligible for propionic acid. This fact can be confirmed also by taking 
into account the three-body association rate constants for this compound, listed in the 
Table 4.5. For the purpose of this experiment, the Nalophan bag with the sample has been 
placed to the thermostat and the temperature has gradually decreased from 37°C to 0°C. 
As can be seen from gathered time profile, the ratio of the count rates of primary product 
ion MH+ and its hydrates is seriously involved by the temperature and humidity, for every 
ion then by different way. Even though, the count rate of MH+ is growing with the 
decreasing temperature and thus also decreasing humidity, the count rate of MH+(H2O)2, 
secondary hydrate derived from protonated molecule, is dropping. The proportion of 
primary hydrate, MH+(H2O), is (as a function of decreasing temperature and humidity) 
growing same as MH+.  Nevertheless, the rate of this change is divergent and at different 
temperatures can be dominant various products. That is the reason, why must be hydrates 
and secondary reactions at all always taken into consideration. 
 
Figure 4.11. The time profile of the humidity drop based on temperature change – propionic acid. 
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Next figure (Figure 4.12) is then showing the graphical overview of individual 
products count rate dependence on the water concentration for acetic acid. The similar 
trend as in case of MIM time profile for Propionic Acid (Figure 4.11) is noticeable. 
In general, the speed of water clusters formation for protonated molecules is 
relatively slow in the case of lower carboxylic acids, but grows with the number of 
carbons. This can be due to the number of degrees of freedom in the reaction intermediate 
resulting into its longer life time. Similar trend was observed previously for the reactions 
of protonated ketones [298].  
 
Figure 4.12. A plot of count rates of individual ions on water concentration – acetic acid. 
 
Hydration of the primary products of NO+ reactions with carboxylic acids was 
again observed and in general, only the monohydrates are created [M+NO]+H2O and [M-
OH]+H2O. The values of the three-body rate constants 𝑘𝑀+𝑁𝑂+/ 𝑘𝑀−𝑂𝐻+ calculated using 
Equations (20) and (21) are given in the Table 4.5. The most efficient formation of the 
water clusters of the [M+NO]+  product ions has been observed for the dehydroxidated 
propionic acid, (see the Table 4.5). Nevertheless, no trend was apparent in the variation 
of 𝑘𝑀+𝑁𝑂+with regard to the change of the carbon atoms number.  
 
2. Possible IBD biomarkers  
In case of possible IBD biomarkers, the formation of the hydrated protonated 
molecules has been observed only for three compounds: 1,3,5-triazine, 2´-
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methylacetophenone and 2-hexanone, whereas the three body association rate constant  
has a higher value only in case of 2-hexanone. In other cases we observed relatively slow 
association reactions. (see the Table 4.6) 
The hydration of the NO+ primary products by the association reactions with H2O present 
in the reactant mixture was observed in case of cis-2-nonen-1-ol, 2-methylacetophenone 
and heptene.  In general, only the monohydrates have been observed and very interesting 
in this study was 1-heptene, where the secondary products were created in case of all 
primary products detected for this compound of interest. As can be seen from the Table 
4.6, the most effective formation of secondary products has been observed for cis-2-
nonen-1-ol.  
As can be seen from the Table 4.6, from the group of investigated IBD possible 
biomarkers, only 2´-methylacetophenone is forming the secondary products for both 
reagent ions, H3O+ and NO+. 
Conclusions 
The three-body association reactions studies discussed in this section provided 
some new data for the kinetics of the reactions important for SIFT-MS quantification of 
carboxylic acids and IBD possible biomarkers in humid air/breath respectively. These 
data have been included in the kinetics library used for automated immediate 
quantification and will help in the future studies, where these compounds can be in the 
area of interest. 
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Table 4.6. Kinetic data for formation of hydrates of primary products of the NO+ and H3O+ reactions with possible IBD biomarkers. 
 
Compound Linear Formula Kinetic data for formation of hydrates of primary 
products of  H3O+ reactions 
Kinetic data for formation of hydrates of primary 
products of  NO+ reactions 
Reaction Seffa Aeffb 𝑘𝑀𝐻+
c 
[10−28 cm6 s−1] 
Reaction Aeffd 𝑘𝐴+
e 
[10−28 cm6 s−1] 
1,3,5-triazine  [MH]++ H2O + He 0.41 1.62 0.73    
cis-2-nonen-1-ol CH3(CH2)5CH=CHCH2OH     [M-H]++ H2O + He 11.58 6.95 
2-methylacetophenone CH3C6H4COCH3 [MH]++ H2O + He 0.41 2.29 1.13 [M]++ H2O + He 0.08 0.05 
1-heptene CH3(CH2)4CH=CH2     [M-(CH2)4+NO]++ H2O + He 
[M+NO]++ H2O + He 
[M-(CH2)2+NO]++ H2O + He 
1.43 
1.05 
1.34 
0.86 
0.63 
0.81 
2-hexanone CH3(CH2)3COCH3 [MH]++ H2O + He 0.39 11.28 6.53    
 
 
a Ligand switching efficiencies calculated from Eq. (16). 
bAssociation efficiencies obtained from experimental data using Eq. (18). 
cThree-body association rate constants calculated from Eq. (19). [10−28 cm6 s−1]  
dAssociation efficiencies obtained from experimental data using Eq. (20). 
eThree-body association rate constants calculated from Eq. (21). [10-27cm6s-1] 
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4.3 Construction and optimization of kinetics library 
Objectives 
Analysis of VOCs via SIFT-MS is not always absolutely easy. One of the today's 
major challenges (despite the development of this method resulted in improvements in 
sensitivity, accuracy and precision of quantification of known compounds present in the 
sample) is represented by the overlapping ion peaks in the mass spectra when isomeric, 
other isobaric compounds or compounds from the same chemical class are present in the 
mixture to be analysed (see the comparison of mass spectra for 2 isobaric compounds – 
ethanol and formic acid – Figure 4.13). In general, this method is still not as reliable for 
identification of unknown compounds in complex mixtures as GC-MS. However, when 
we consider the availability of three reagent ions, we have still (in most of the cases) the 
opportunity to distinguish between investigated compounds of the same molecular weight 
- by virtue of the different reaction processes that are for the investigated compounds 
characteristic [47]. 
 
Figure 4.13. The SIFT-MS spectra obtained using the O2+•precursor ions when ethanol or formic acid 
is introduced into the helium carrier gas; ion count rates are given on semilogarithmic scale as a function 
of m/z. Note the characteristic ion products at m/z 45 and 46 for both products and the characteristic ion 
product for ethanol at m/z 31. 
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Methods 
In case of SIFT-MS analysis, the determination of absolute concentrations of 
compounds in real time is based on obtaining the ratio of the sum of several product ion 
count rates to the sum of the reagent ion count rates. These values are than weighted by 
the reaction rate constants and additional coefficients can be also applied to account for 
special circumstances, such as overlaps (contributions of the different compounds with 
characteristic ions at the same m/z value). All the calculations are conducted by the SIFT-
MS analytic software on-line, taking the rate constants and other coefficients from the 
kinetic library [259], whereas the construction of entries for the kinetic library is one of 
the key steps for any project. The kinetic data as the entries for kinetic library must be for 
the purpose of SIFT-MS analytic software in the special format. An example of kinetic 
data in such format is available in the Table 4.7. It is the kinetic library, standardly used 
for analysis of the carboxylic acids by using of the H3O+ reagent ion.  
 
Table 4.7 SIFT-MS kinetics library in the format required by the SIFT-MS software for on-line calculations 
of the concentrations of the carboxylic acids. 
Formic Acid (H3O+) Acetic Acid (H3O+) Propionic Acid (H3O+) Butyric Acid (H3O+) 
4 precursors 4 precursors 4 precursors 4 precursors 
  19 2.2e-9 1.0   19 2.6e-9 1.0   19 2.7e-9 1.0   19 2.9e-9 1.0 
  37 1.9e-9 1.0   37 1.9e-9 1.0   37 1.9e-9 1.0   37 1.9e-9 1.0 
  55 1.9e-9 1.0 
  73 1.8e-9 1.0 
  55 1.9e-9 1.0 
  73 1.8e-9 1.0 
  55 1.9e-9 1.0 
  73 1.8e-9 1.0 
  55 1.9e-9 1.0 
  73 1.8e-9 1.0 
2 products 3 products 4 products 3 products 
  47 -0.028   61 1.0   57 1.0   89 1.0 
  65 0.51   79 1.0   75 1.0   107 1.0 
  83 0.51   97 1.0   93 1.0 
  111 1.0 
  125 1.0 
 
In our experiments, we have optimised the kinetic library for easy distinguishing 
of the formic acid from the ethanol by utilisation of the NO+ and O2•+ reagent ion 
(Appendix A). We have also used the updated kinetic library entries in case of alkenes 
(Appendix C). The construction of more advanced entries accounting for overlaps of the 
product ions is described step by step in the following text. 
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Results and Discussion 
This subsection summarize and complement the data concerning the carboxylic 
acids and alkenes, thus those published in impacted peer reviewed journals attached 
bellow - Appendix A [280] and Appendix C [169]. 
The fundamentals for any kinetic library construction and the following 
optimisation are the kinetic data of the reactions of H3O+, NO+ and O2+• with compounds 
of interest. Such a data, which were discussed previously (see the sections 4.1 
Determination of rate constants and product ion branching ratios and 4.2 Three-body 
association reactions – ion chemistry involving water molecules) can be used to construct 
an initial simple version of the kinetics library entries as given in Table 4.7. For example, 
for acetic acid, the following details are given according to the required format: 
 appropriate reagent ion (H3O+), which means listing all four m/z values 
including the H3O+ hydrates (19-37-55-73) together with the appropriate rate 
constant obtained theoretically or derived experimentally;  
 the fp coefficient at the default value of 1.0 (values other than 1.0 can be used 
to multiply the corresponding ion count rates in order to optimize kinetics 
entries, as it will be shown below); 
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Figure 4.14. (a) Time profile of the concentration of formic acid and ethanol calculated (in ppmv) simply 
from the sum of the characteristic product ions in a validation experiment when diluted samples of reference 
compounds are introduced sequentially for NO+ precursor and m/z 45 and 76 product ions. Plot (b) shows 
the same raw experimental data evaluated using the optimised kinetic library; note that cross sensitivity has 
been dramatically reduced. Plots (c and d) shows the similar data, only by using O2+• reagent ions and m/z 
45 and 46 product ions for formic acid and m/z 31, 45 and 46 product ions for ethanol.  
 
 
  the number of product ions (m/z 61, 79, 97) formed by primary and secondary 
ion-molecular reactions with each m/z value  
 the default fi coefficient of 1.0.  
 
The initial kinetic library entries compiled according to the instructions above 
must be subsequently validated for the effect of ion overlaps by analysing real samples. 
Usually, the reference mixtures (at approximately 1 ppmv concentration) of compounds 
of interest are analysed in the MIM mode by using the relevant reagent ions (NO+ and 
O2+• in case of formic acid/ethanol study; H3O+ in case of alkenes study). Because the 
gathered time profiles indicated the cross sensitivity (see Figure 4.14 as example of cross 
sensitivity between formic acid and ethanol), it was clear that the optimised kinetic library 
entries are necessary. The selection of the appropriate process in the course of cross 
sensitivity eradication may vary case to case. Therefore, the group of investigated 
compounds must be evaluated, same as signs of overlaps and their background.  
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In some cases can be the problem of m/z overlaps solved simply by exclusion of 
some minor product ions from the final library. This procedure is typical, when the 
compounds with increasing number of carbons from one chemical class are investigated. 
This solution has been (during my studies) used for example in case of project focused 
on alkenes investigation – see Appendix C).   
In case of carboxylic acid study, where we tried to minimize the effect of product 
ion overlaps between ethanol and formic acid, the main idea in constructing kinetic library 
entries lied in finding the linear combinations of ion product count rates that would allow 
selective quantification of these compounds. It is important to highlight, that this solution 
requires addition of the ion count rates of the hydrated ions (in case when these are 
formed) to the ion count rates of the corresponding primary product ions. This must be 
conducted to achieve validity of the results for any concentration of water in the sample. 
Such linear combination can be found by the simple solution of a set of the linear 
equations [297] and the procedure has been used for kinetic library entries by using the 
NO+ and O2+• reagent ions. The model Equations 22-24 are related to measurements with 
utilisation of the NO+ reagent ions: 
 
𝐹 = 𝑓𝐹  [45]𝐹 + 𝑔𝐹  [76]𝐹                               (𝑎)                          (22)  
 𝐸 = 𝑓𝐸  [45]𝐸 + 𝑔𝐸  [76]𝐸                                (𝑏)                              
 
Here F represents the linear combination used to quantify formic acid and E represents 
the linear combination to quantify ethanol. The square brackets indicate the product ion 
count rates registered when the compound indicated by subscripts F (formic acid) and E 
(ethanol) is introduced into SIFT-MS. The constraints on the coefﬁcients f and g (treated 
as the unknowns in the set of equations) are given by the requirement of calculating zero 
concentration of F when only E is introduced and oppositely: 
0 = 𝑓𝐹  [45]𝐸 + 𝑔𝐹  [76]𝐸                                (𝑎)                           (23)  
 0 = 𝑓𝐸  [45]𝐹 + 𝑔𝐸  [76]𝐹                               (𝑏)                              
 
By using these equations, it is possible to calculate f and g coefﬁcients (fp factors used 
within the optimised kinetic library to multiply the acquired raw count rate of the ion, 
accounting so for the overlaps) from the experimental data of ion count rates using the 
pure compounds. The calculation procedure is described below. 
 First of all, factors fE and fF have been expressed from the Equation 23 (a,b): 
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𝑓𝐹 =  −𝑔𝐹 
 [76]𝐸
[45]𝐸
                                                 (𝑎)                          (24)  
𝑓𝐸 =  −𝑔𝐸 
 [76]𝐹
[45]𝐹
                                                 (𝑏)                              
    
Subsequently, these factors were substituted into Equation 22 (a,b), where F and E 
represent the total count rate of both ions. Thanks to this, it is possible to express 
numerically the factors gF and gE, and finally also the factors fF and fE . 
Similar experiments and calculations were used also to resolve m/z overlaps 
between formic acid and ethanol (O2+• reagent ions). All the results are available in the 
relevant manuscript (Appendix A). 
 
Conclusions 
The possible methods for optimised kinetic library construction have been 
discussed and described. Those are essential for accurate determination of absolute 
concentrations of compounds of interest. In addition, optimised kinetic data entries could 
be the solution for the ongoing SIFT-MS challenge - overlapping ion peaks in the mass 
spectra when isomeric, other isobaric compounds or compounds from the same chemical 
class are present in the mixture to be analysed. 
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4.4 Breath analysis and searching for the new biomarkers 
 
Objectives 
The main and ultimate goal of my PhD research project was (already from the 
onset) breath analysis for clinical diagnosis and monitoring of therapy, whereas all the 
investigations concerning reaction kinetics, development of new reaction schemes and 
methodologies in SIFT-MS have been the activities precedent and essential for reaching 
of this goal. Our interest in the area of breath analysis has been after the long decision 
process focused on inflammatory bowel diseases (IBD), the group of disorders causing 
inflammation of the gastrointestinal tract. The main reasons for this choice was mainly 
the previous success of the local investigation team with research in this area (detection 
of exhaled pentane concentration as a biomarker of lipid peroxidation [168]). Then also 
the fact, that interesting results were presented for this topic at the time of our decision-
making (f.e. research patents identifying some VOCs as being present in modified 
concentrations in the breath of patients with IBD [179-182]). Also, the increasing 
incidence and prevalence of these inflammatory conditions in Europe, lack of a single 
gold standard, multimodal approach for the diagnostics and limited sensitivity or 
invasiveness of currently available methods supported our decision (see section 2.3.3 
Inflammatory bowel disease for additional details). 
On the beginning of our breath analysis project, the detailed study of the ion 
chemistry of several possible breath biomarkers of IBD [165] (see Appendix B) has been 
conducted. The compounds included in this study (the group consisting of some 
hydrocarbons, aromatic compounds, ketones or alcohols) have been carefully selected 
from the above mentioned patents. Data obtained in this experiment facilitated SIFT-MS 
analyses of the studied compounds in the presence of water vapour in biological samples 
including exhaled breath.  
As the following step, it was necessary to get an idea about the actual breath 
concentrations of these compounds in exhaled breath of health population and IBD 
patients (our preliminary measurements indicated the values typically below 10 ppbv and 
possibly below 1 ppbv). A  study has been carried out of IBD possible biomarkers in the 
exhaled breath of patients suffering from IBD, comprising 136 with Crohn’s disease (CD) 
and 51 with Ulcerative colitis (UC), together with a cohort of 14 healthy persons as 
controls. Breath samples were collected by requesting the patients to inflate Nalophan 
   
 111 
bags which were than quantitatively analysed using SIFT-MS. The breath samples for 
this study were obtained in cooperation with ISCARE Clinical and Research Centre for 
Inflammatory Bowel Disease in Prague. The data acquired within this project shown some 
interesting results, specifically elevated ion signal at m/z 99 observed in the H3O+ SIFT-
MS analyses of breath of IBD patients, [183] that may be characteristic for heptene. 
Except of this curious result, concentrations of all the remaining IBD possible biomarkers 
shown to be typically in the range < 5 ppbv, as can be seen from the Figure 4.15. 
Although, during the course of my PhD project, the elevated signal at m/z 99 has been 
finally explained by presence of impurities released over the time from the Nalophan 
sampling bags (influence of the gathered results by the false positive signal - see the 
Section 4.5 Challenges in connection with breath analysis - Nalophan sampling bags), 
the ion signal at m/z 99 observed during our pilot study has been quite significant. Taking 
into account the study of Patel et al. [167], which supported the hypothesis that alkenes 
are possible IBD biomarkers, it was clear, that further work will be necessary to establish 
the diagnostic value of SIFT-MS measurement of these compounds. 
 
Figure 4.15. The average concentration of IBD-potential biomarkers in real samples of human breath 
(Cohort of subjects from the ISCARE Clinical and Research Centre for Inflammatory Bowel Disease in 
Prague - 136 patients with CD, 51 with UC and 14 healthy controls). 
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 To achieve this point, it was decided to conduct the detailed study of the ion 
chemistry of alkenes focusing on heptenes [169] and to use the gathered results (ion-
molecule kinetics data) for additional investigation in this area (in the subsequent step to 
confirm or exclude presence of alkenes directly in the real breath samples of healthy 
population and finally to compare gathered results with those obtained for IBD suffering 
patients). Such an effective addition of several entries to a SIFT-MS library for alkenes 
allowed ultimately fast SIFT-MS analyses of breath samples and the quantification of 
alkenes for the purpose of IBD diagnostics (see the Appendix C: A detailed study of the 
ion chemistry of alkenes focusing on heptenes aimed at their SIFT-MS quantiﬁcation for 
additional details).   
Before we have proceeded to our follow-up research project, the available 
literature with a focus on previous observations concerning heptene or m/z 99 mass peaks 
was reviewed, to compile as much as possible knowledge at this level. Alkenes, resp. 
analytes leading to the characteristic proton transfer product ion at m/z 99, have been 
observed in several areas of research. In the medical science for example in connection 
with chronic liver disease (CLD) in children, where 1-heptene, 1-octene and 1-decene (as 
analysed by SIFT-MS) were selected as breath VOCs, which can in combination with 
others VOCs predict CLD presence [299], or in connection with oral candidiasis, where 
the pattern containing nine compounds including 1-heptene was identified by GC-MS, 
showing characteristic changes in patients before and after antifungal therapy [300]. 1-
heptene levels were investigated also in connection with carcinoma. The work of 
Mochalski et al. studied release and uptake of volatile organic compounds by human 
hepatocellular carcinoma cells and 1-heptene was one of the compounds identified by 
GC-MS playing role in metabolism of these harmful cells [301]. In connection with 
cancer, in this case lung cancer, ion signal at m/z 99 was also investigated, which was 
identified as one of the markers for bronchial adeno carcinoma. Nevertheless, the ion 
signal at m/z 99 was in this study tentatively identified as C6H10O (e.g. Hexenal) or 
C5H6O2 (e.g. Furanmethanol, 2-methyl-3(2H)-furanone) by proton transfer reaction time 
of flight mass spectrometry, PTR-TOF-MS [302]. The ion signal at m/z 99 was monitored 
also in the PTR-MS study focused on elimination characteristics of post-operative 
isoflurane levels in alveolar breath [303]. Another area of research where the signals of 
product ion at m/z 99 (in case of PTR-MS and H3O+ reactions) can be important is food 
industry or environmental and industrial monitoring.  
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To summarize all the retrieved data, heptenes and product ions at m/z 99 were 
observed in various studies of VOCs. Unfortunately, the presence of m/z 99 can be 
interpreted by individual research groups differently, because it can in the environment 
of PTR-MS and SIFT-MS result from many different compounds. Alkenes and heptenes 
can be thus possible markers not only for IBD, but they can signalize many different 
medical problems or body states (as can be seen from the text above).  
 
Methods 
Breath samples 
The group of ostensibly healthy volunteers (no acute or chronic disease has been 
reported at the time of investigation) were recruited from colleagues involved in this study 
and from the local academic team. The study was approved by the ISCARE I.V.F. a.s. 
institutional ethics committee. Breath samples (on average 3-4 for any volunteer, to 
achieve quality and integrity of the gathered data and to exclude random false positive or 
negative results) were collected into 25 µm Nalophan sample bags (Kalle CZ, Žebrák, 
Czech Republic) of 3 L volume and after approximately 5 minutes placed into an 
incubator held at 37⁰C. To allow correct identification of alkenes (in case that these 
compounds would be present in breath), we have collected also samples of breath after 
exposure to compound standards and breath samples spiked by compound standards. The 
following reagents were used for this purpose: 1-hexene, 97%, Sigma-Aldrich; 1-heptene, 
neat, Supelco; trans-2-heptene, 99%, and 3-heptene (cis and trans), ≥ 95%, Chromservis; 
1-octene, neat, Supelco; 1-nonene, 99,5%, and 1-decene, 94%, Sigma-Aldrich.   
The protocol for obtaining the samples of breath after exposure required the 
volunteer stay in the designated laboratory room with open flasks of alkenes standards 
for 1 minute and immediate collection of the breath to the Nalophan sample bag. From 
the other side, breath samples spiked by compound standards have been prepared by 
gradual addition of individual alkenes (in total 3 ml headspace of each of 7 compounds 
of interest) to the breath of few randomly selected volunteers. Also these “special” 
samples have been after 1-2 minutes transferred to the incubator held at 37°C.  
Breath samples for long-term observational, comparative analysis of heptene 
levels in case of IBD suffering patient (CD in remission, biological treatment) and control 
have been collected and processed in the same way as the rest of samples. 
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SIFT-MS analysis of exhaled breath with a focus on presence of alkenes 
Off-line SIFT-MS analyses by using H3O+ reagent ion were started immediately 
after sample collection, even before placing the bag to the incubator. This protocol has 
enabled to observe changes in the representation of the monitored substances in relation 
to the temperature, because the room temperature was much more lower (approximately 
25°C). Alkenes were quantified by using the multiple ion monitoring (MIM) mode and 
the special kinetic library, which was created specifically for the purpose of monitoring 
of alkenes. The total analysis time for each bag sample, including the data storing time, 
was about 30 minutes. The background concentrations of all included compounds were 
recorded in order to ensure that the inhaled concentrations were negligible [96]. 
 
GC-MS analysis of exhaled breath with a focus on presence of alkenes 
For the purpose of GC-MS analysis, the breath VOCs were extracted using solid 
phase microextraction (SPME) onto CAR/PDMS - coated fibres (carboxen/ 
polydimethylsiloxane; Supelco, Bellefonte, PA, USA) for 30 min at a temperature 37°C. 
To achieve the smooth course of analysis for all bag samples, the protocol of this study 
required the start of extraction simultaneously with the start of SIFT-MS analysis. When 
the extraction has been finished, the SPME fibres were directly inserted into the injector 
of the GC-MS instrument (FOCUS GC with instant connect Split/Splitless injector (SSL), 
ITQ 700 ion trap mass spectrometer using electron ionisation) held at 210 °C. The time 
of desorption was 5 minutes using the splitless injection mode. The GC conditions were 
as follows: GC oven temperature program 38°C (hold 8 min), 4°C/min ramp up to 100 
°C, 30°C/min to 210°C, and a final hold 3 min (total run time 30.17 min). GC-MS 
capillary column TG-624 (fused 100% Cyanopropylphenyl Polisiloxane, 30 m × 0.25 mm 
ID × 1.0 um film) was used. Electron ionisation at 70 eV generated ions that were 
analysed by the ion trap operating in the scan mode (m/z 15–400, scan rate: 1 scan/s). The 
instrument setup and the method has been developed directly for the need of off-line GC-
MS analysis of VOCs from breath by using CAR/PDMS-coated fibres and have been 
successfully used in previous studies [202,304]. The results for breath were finally 
compared with the results gathered for breath samples spiked by compound standards and 
with the results gathered for breath samples after exposure to these compounds. Thus, the 
identification of alkenes has been conducted with a help of standards (confirmation of 
retention time and mass spectra with samples obtaining standards). The results were 
finally verified with the help of NIST 2.0 library. 
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Comparison of the SIFT-MS and GC-MS results 
Whereas the benefits of SIFT-MS in case of this study are mainly in its easy and fast use 
for quantification of alkenes, a problem which persists are the ion signal overlaps (m/z) 
of product ions and therefore uncertainty with identification of compounds present in 
breath - in general the non-specificity of this method. This problem was in our study 
solved by using a second analytical technique, in our case GC-MS, which allows easy 
identification of alkenes. Combination of both these methods finally allowed qualitative 
and also quantitative analysis, which was confirmed with a help of correlation analysis. 
 
Results and Discussion 
SIFT-MS as a method suitable for alkenes detection 
The results gathered within this study confirmed the suitability of SIFT-MS method for 
analysis of alkenes in breath. The mean values of alkenes concentrations in breath of 
healthy volunteers (in ppbv) are given in Table 4.8, same as mean values for samples of 
breath after exposure to compound standards and breath samples spiked by compound 
standards. As can be seen from this table, in cases when alkenes are really present in the 
human breath, SIFT-MS can be the reliable method for their detection, even in the case 
of their low representation. The average concentrations of all investigated alkenes in 
breath are generally below 10 ppbv and in comparison with breath samples after exposure 
to compound standards or breath samples spiked by compound standards are negligible.  
The only exception in our study was the 1-heptene (sample stored in the incubator set up 
to 37°C), where was the concentration more than 20 ppbv (reasons for this explained 
below). This result is in a good agreement with the generally accepted assumption that 
these compounds shouldn’t be presented in the breath of healthy people in higher 
concentrations and their low representation should be in normal situation related to 
exogenous factors (environment, life style, nourishment) [305]. We can also confirm, that 
the observed values are comparable with the above-mentioned work of Eng et al., where 
the levels of alkenes (series from heptene to decene) are generally also below 10 ppbv. 
The differences in the obtained results can be given by the fact, that in case of Eng et al., 
Mylar bag was used instead of Nalophan bag [299]. When we will focus on concentration 
of alkenes in breath after exposure to compound standards, they are in the range of 
hundreds for lower alkenes, such as 1-hexene (mean value: 217 ppbv) and heptene (150 
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ppbv) and in the range of units for higher alkenes, such as 1-nonene (3.3 ppbv) and 1-
decene (5.5 ppbv). Values for 1-octene lays in the order of tens (48 ppbv). In case of 
breath samples spiked with alkenes standards we can observe the same trend, but in this 
case are the mean values in comparison to values obtained for breath exposed to alkenes 
even many times higher. For 1-hexene was the mean concentration 24514 ppbv and for 
heptene 7218 ppbv. The values for higher alkenes were than 513, 48 and 8.3 ppbv (1-
octene, 1-nonene, 1-decene). Based on these learnings it is possible to say, that analysis 
and detection of higher alkenes may be more problematic because of their lower 
representation 
 
Table 4.8. A list of alkenes concentrations for the breath samples of healthy volunteers, breath 
samples after exposure to alkenes and samples of breath spiked by compound standards as 
measured by SIFT-MS (MUI mode, H3O+ reagent ions). The median values are in ppbv, range of values 
is in %.  
 
Compound 
of interest 
Reagent Product ions 
used for calc. 
Breath samples 
(room temperature*) 
Breath samples 
(incubator**) 
Breath after exposure to 
alkene's standards 
Breath samples spiked 
by alkene's standards 
1-hexene H3O+ m/z 85 0.96 0.93 217 24514 
+/-   31% 20% 1% 2% 
heptene H3O+ m/z 99 4.5 24 150 7218 
+/-   19 % 5% 2% 1% 
1-octene H3O+ m/z 113 2.5 2.6 48 513 
+/-   21% 14% 3% 4% 
1-nonene H3O+ m/z 127 0.23 0.30 3.3 48 
+/-   56% 46% 12% 7% 
1-decene H3O+ m/z 141 0.14 0.13 5.5 8.3 
+/-   36% 20% 10% 10% 
* air conditioner set up on 25°C 
** incubator set up on 37°C 
 
 
Comparison of SIFT-MS and GC-MS results, correlation analysis 
As it is mentioned above, all the samples have been analysed not only by SIFT-MS 
technique, but also by GC-MS to achieve the correct interpretation of results in terms of 
identification of individual alkenes. The correlation analysis has been conducted for all 
compounds of interest and the harmony of results gathered by SIFT-MS and GC-MS has 
been tested. The best value was determined for 1-hexene, where we achieved the result 
R2=0.94. Good results were achieved also in case of heptene R² = 0.88 (peak of heptene 
eluted at retention time (RT) =11.66), respective R² = 0.91 (peak of heptene eluted at 
RT=12.86), but they were not very convincing in case of 1-nonene and 1-decene. There 
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may be many reasons for this fact, including SPME limitations, the decreasing volatility 
in the series of alkenes or time delay between both analytical processes. 
 
Is the ion signal at m/z 99 really heptene? 
In the case of this study we have determined again interesting results for heptene. 
As can be seen from the Table 4.8 above and also from the Figure 4.16, on the assumption 
that SIFT-MS characteristic ion m/z 99 is assigned to heptene, the result indicated higher 
representation of this compound for breath samples placed to the incubator in comparison 
with those stored at room temperature. Because the concentration of heptene in heated 
breath sample was approximately 4 times higher than concentration of heptene in breath 
sample stored at room temperature (24 ppbv respective 4,5 ppbv), the question was 
opened, whether we can the ion signal recorded in case of heated breath samples at m/z 
99 really use for calculation of heptene concentration, or whether we monitor the signal 
of another compound. This question was opened beside the fact that the achieved results 
of correlation analysis were quite promising, as can be seen in the paragraph above.  
 
 
Figure 4.16. Box-and-whiskers plots of breath alkenes concentrations for the samples stored at 
incubator. Median values are indicated. 
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We have therefore tried to investigate in detail the data gathered by both methods 
with an ultimate goal to identify a compound, which could represent ion signal at m/z 99 
with a higher certainty. To achieve this, it was necessary to re-investigate the results 
gathered by GC-MS analysis and identify all possible peaks with an occurrence of the ion 
signal in the m/z range from 98 to 100. The identified peaks have been than evaluated and 
obtained results later compared with the data gathered by SIFT-MS for the same samples. 
The correlation analysis between SIFT-MS data for m/z 99 and GC-MS results provided 
in many cases promising results and finally we have realised, that the compound giving 
the signal at m/z 99 could be any impurity released from the Nalophan sampling bag 
(ethylene glycol - C2H6O2; MW 62). This challenge has been further investigated and all 
the circumstances are summarised in the section bellow (4.5 Challenges in connection 
with breath analysis - Nalophan sampling bags) and also in the relevant manuscript 
(Appendix D). 
 
Comparison of Data for healthy volunteer and IBD suffering patients 
Within this study we have conducted also long-term systematic, comparative 
analysis of breath of two volunteers with a focus on monitoring of heptene 
concentration/ion signal at m/z 99. This observation lasted for approximately 1 month (20 
working days)  and it was focused on 2 volunteers, specifically 1 healthy subject (control) 
and 1 IBD patient suffering by UC (biological treatment, illness in remission). The results 
shown slightly increased levels of heptene, respectively ion signal at m/z 99 for IBD 
patient. The value was in average 11.3 ppbv. 
 
Conclusions 
In general, this research project was targeted on analysis of breath of healthy 
population with a focus on alkenes (from 1-hexene to 1-decene) and determination of 
their mean concentration. Part of this study was also a pilot work comparing data for IBD 
suffering patient and control. To summarize the obtained results, SIFT-MS is a technique 
capable to conduct analysis of alkenes in breath (when they are really present in the 
sample). Nevertheless, it is very important to highlight, that only breath samples stored at 
the room temperature for as short time as possible are suitable for this type of analysis. In 
case when the samples of high humidity and temperature higher than 25°C would be 
analysed, there is a risk of getting the false positive signal, as the m/z 99 measured in case 
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of these breath samples can have origin in other compound (impurities released from the 
Nalophan sampling bag, namely ethylenglycol). This problem is also multiplied by the 
length of storage. All these facts played an important role also in obtaining false positive 
signal during our pilot study, where samples from IBD suffering patients obtained in 
cooperation with ISCARE Clinical and Research Centre for Inflammatory Bowel Disease 
in Prague have been analysed.   
The mean concentrations of alkenes in the breath of healthy people, as determined 
by this study, are usually below 10 ppbv. The comparison of results obtained for healthy 
volunteer and IBD suffering patient confirmed the hypothesis, that presence of heptene 
in the breath of IBD suffering patient is higher.  
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4.5 Challenges in connection with breath analysis - Nalophan 
sampling bags 
 
Objectives 
Even though the analytical techniques are available for on-line real time analysis 
of exhaled breath (as already mentioned in the theoretical part of this thesis - Section 2.2 
Sampling and analysis), e.g. SIFT-MS and selected ion flow-drift tube (SIFDT-MS) 
[306],  PTR-MS, IMS, absorption spectroscopy or SESI-MS [307,308], off-line analyses 
are still very important and frequently utilised. The reason are in particular the following 
major drawbacks of on-line techniques: the cost of the instrumentation, problems with 
the movement of usually very large devices and the fact, that longer analyte ion 
integration times can be used in the case of off-line analysis to improve analytical 
sensitivity. The off-line exhaled breath analysis is typically carried out by collecting a 
sample in a suitable container prior to extraction or analysis.  
The sampling procedure and the sample stability in general are the most critical 
steps in the entire analytical procedure. In fact, preservation of the sample integrity during 
sampling and sample storage is probably one of the most demanding challenges in 
analytical chemistry. It can be accompanied by phenomena like interaction with the 
sampling container (adsorption/desorption processes and release from the container 
material itself) or permeation through the container walls (loss of sample components and 
contamination of external pollutants). Chemical reactions facilitated by high sample 
humidity can also occur, especially at long storage times [118]. These problems are 
aggravated in case of breath analysis because of the very low concentrations of many 
volatile metabolites (from ppbv to low pptv) some of which are very reactive species like 
aldehydes and unsaturated organic compounds. 
The standard containers for sampling have been already discussed in the 
theoretical part of this thesis (Section 2.2.4 Storage, stability and sampling containers for 
breath analysis), where some additional details concerning this topic can be found. Just 
to summarize, polymer sampling bags are very often used, namely Tedlar (PVF, polyvinyl 
fluoride), Teflon (PTFE, polytetrafluoroethylene), Metal-coated multilayer bags (Flexfoil 
and polyester aluminium, PEA) and Nalophan (PET, polyethylene terephthalate).  
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In our study we have focused on the Nalophan sampling bags, especially because 
of their high popularity in Europe and extensive use in the field of breath analysis, which 
is probably also supported by the fact, that Nalophan bags have been evaluated in the 
previous studies as best choice for the collection of breath samples in terms of 
contaminants released during storage, good sample stability (up to 24 h for both dry and 
humid samples), and very limited costs. However, previous studies have reported some 
impurity compounds in Nalophan bags including 2-methyl-1,3-dioxolane [115, 309]. 
Because this compound can react with hydrogen sulphide [310], it is not recommended 
to use Nalophan sampling bags for analysis of compounds containing sulphur [112].  
Over the years, the product ions at m/z 45, 63 and 81 were commonly observed in 
SIFT-MS analyses of breath stored in Nalophan bags using the H3O+ reagent ions (not 
only by our research group, but also in different laboratories and for separately acquired 
Nalophan material). This signal was (in retrospect incorrectly) attributed to acetaldehyde 
[130]. Nevertheless, the study of alkenes (see the chapter above - 4.4 Breath analysis and 
searching for the new biomarkers) encouraged the idea, that another compound could be 
responsible for this signal. Based on some pilot studies of Nalophan bag samples using 
GC-MS we noted that this compound could be attributed to 1,2-ethanediol (ethylene 
glycol) released from the Nalophan material. Therefore, we have decided to revisit this 
important topic. It was done by investigating the release of VOC impurities into Nalophan 
bags using three analytical methods, viz. gas chromatography mass spectrometry, GC-
MS, SESI-MS and SIFT-MS. The objective of this study was to identify main VOCs 
released by Nalophan, to examine the ion-molecule reaction kinetics and also to evaluate 
the influence of storage time, temperature and sample humidity on the release rate of the 
identified VOCs. 
 
Methods 
Nalophan bag construction 
The bags used for this study were fabricated from a roll of a Nalophan tube with 
a diameter of 15 cm and a thickness of 25 μm (Kalle, Germany). The method of Nalophan 
bags fabrication previously described by Ghimenti [115] was slightly modified. 60 cm 
long pieces of Nalophan tube were sealed at one end by z-folding and tightened by a 
nylon cable tie. Similarly, the other end was also z-folded and a 1 mL disposable syringe 
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was inserted and tightened by a cable tie. The volume of these approximately cylindrical 
bags was 8 L and their inner surface area was 2400 cm2. The bags were first flushed and 
then refilled with dry cylinder nitrogen (Messer) and after a suitable lapse period (see 
later) the nitrogen gas was analysed, as described later. To investigate the influence of 
water vapour, 100 μL of liquid water was injected into the nitrogen. Experiments were 
carried out for both the “dry” and “humid” bags at room temperature (about 21°C) and at 
37°C using a thermostat. All analyses for trace VOCs using GC-MS, SESI-MS and SIFT-
MS were repeated in triplicate. To support our gathered results, the further checks have 
been conducted with a new Nalophan roll, in order to check for material contamination. 
These additional results only confirmed the previous ones.  
 
Gas chromatography mass spectrometry (GC-MS)  
The VOCs were extracted from the nitrogen contained in the Nalophan bag using 
the conventional solid phase microextraction (SPME). Thus, a carboxen/ 
polydimethylsiloxane coated fibre (CAR/PDMS; 75 μm diameter, 1 cm length, Supelco) 
was exposed for 30 min in the nitrogen. To achieve consistent analyses for all bag 
samples, the SIFT-MS and SESI-MS analyses began at the start of the SPME extraction. 
The SPME fibres were introduced into the injector of the GC-MS instrument (FOCUS 
GC with SSL, ITQ 700 ion trap mass spectrometer using electron ionisation) held at 
210°C. The time of desorption was 5 minutes using the splitless injection mode. An 
intermediate polarity VOCOL Capillary column (Supelco, 30 m × 0.25 mm, 1.50 μm) 
was used for the analyses and the GC temperature program was as previously used 
(section 4.4 Breath analysis and searching for the new biomarkers) viz. GC oven 
temperature program 38°C (hold 8 min), 4°C/min ramp up to 100°C, 30°C/min to 210°C, 
and a final hold 3 min (total run time 30.17 min). Electron ionisation at 70 eV generated 
ions that were analysed by the ion trap operating in the scan mode (m/z 15 – 400, scan 
rate 1 scan/s).  
 
Secondary electrospray ionisation mass spectrometry (SESI-MS)  
In secondary electrospray ionization – mass spectrometry (SESI-MS), trace VOCs 
in a sample gas are ionized at atmospheric pressure and detected by a mass spectrometer. 
It has shown promise in a number of applications calling for fast and sensitive analysis of 
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VOCs. For the present study, a home-built SESI source [311] was coupled to a 
commercial ion trap mass spectrometer LCQ Deca XP (Thermo Finnigan). The SESI 
source consisted of a cylindrical stainless steel reaction chamber with two observation 
windows (glass), two inlets (electrospray and sample inlet) and one outlet (connected to 
an MS transfer capillary). Coaxial with the inlet of the mass spectrometer, an uncoated 
fused silica capillary (internal diameter 20 μm, TaperTip Emitters) was fixed in the 
chamber wall to establish an electrospray. The spray was pneumatically supplied (approx. 
500 mbar overpressure of air) with 0.1% formic acid (98%; Sigma-Aldrich) solution in 
pure water from a reservoir to which high voltage (+ 3.5 kV) was applied by a platinum 
wire. Gas samples were introduced into the reaction chamber where gas phase ionization 
by the electrospray generated ions took place. The mass spectrometer was set to acquire 
mass spectra in the low mass range (m/z 15–200, low mass cut-off was m/z 15) in the 
positive ionization mode.  
Selected ion flow tube mass spectrometry (SIFT-MS)  
Data for the present study were obtained using the full scan (FS) mode of the 
downstream analytical mass spectrometer(m/z range 10-200, scan rate 100 s/scan) with 
all three available reagent ions (H3O+, NO+, and O2+•) and the multiple ion monitoring 
(MIM) mode involving rapid switching between selected analyte ions. The total analysis 
time for each bag sample, including the data saving time, was about 30 minutes.  
 
Results and Discussion 
The following text summarizes and complements the data concerning the 
challenges in connection with Nalophan sampling bags, as published in the relevant 
article (Appendix D) [312]. In summary, basic features of the GC-MS, SESI-MS and 
SIFT-MS data obtained for the analysis of the nitrogen contained in the Nalophan bags 
are presented.  
 
Gas chromatography mass spectrometry (GC-MS)  
Sample chromatograms resulting from an unexposed SPME fibre and one exposed 
to the nitrogen bag gas are shown in Figure 4.17. These chromatograms are remarkably 
clean showing in Figure 4.17a only the silanediol and siloxane emitted from the SPME 
fibre and two additional peaks in Figure 4.17b. These two additional peaks are attributed 
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to the ethylene glycol and 2-methyl-1,3-dioxolane. The elution times for these two 
compounds were confirmed using 99% pure compounds standards (Sigma-Aldrich).  
 
 
Figure 4.17. Total ion current gas chromatograms obtained for a) blank SPME fibre and b) nitrogen 
gas stored in a Nalophan bag for 1 hour at 37˚C. 1. dimethylsilanediol; 2. hexamethylcyclotrisiloxane 
(both from the SPME fiber); 3. 2-methyl-1,3-dioxolane and 4.1,2-ethanediol (ethylene glycol) (both 
released by the Nalpohan bag material). 
 
Ion chemistry relating to the analysis of selected VOCs by SIFT-MS and SESI-MS 
Detection and quantification of specific VOCs by SIFT-MS and SESI-MS 
requires a detailed knowledge of the ion-molecule chemistry and the reaction kinetics by 
which analyte ions are formed. Although these data were at the time of our study available 
for ethylene glycol (1,2-ethanediol), they were not available for 2-methyl-1,3-dioxolane. 
So, as a part of this study we had to obtain the kinetics data for the reactions of SIFT-MS 
reagent ions with 2-methyl-1,3-dioxolane using the Profile 3 instrument (see sections 4.1 
Determination of rate constants and product ion branching ratios, 4.2 Three-body 
association reactions – ion chemistry involving water molecules and 4.3 Construction 
and optimization of kinetics library for additional details about the general process for 
gathering of these data). To achieve the up-to-date data under the same experimental 
conditions, those for ethylene glycol were also obtained under the same conditions. The 
obtained kinetics data for the H3O+ and NO+ reactions are given in Table 4.9. The more 
complicated O2+• data are not provided, as they are not relevant for the present study. 
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Table 4.9. Kinetics data for the reactions of H3O+ and NO+ ions with ethylene glycol and 2-methyl-
1,3-dioxolane. The branching percentages for the primary reactions only are given together with their 
observed major hydrates. 
 
Compound H3O
+   NO+  
MW, formula ka product ions ka product ions 
ethylene glycol 
(MW 62) C2H6O2 
3.2 m/z 45 (M-OH)+            40% 
m/z 63 MH+                    60% 
m/z 81 MH+H2O  
2.0 m/z 61 (M-H)+     60% 
m/z 92 MNO+      40% 
 
2-methyl-1,3-
dioxolane 
(MW 88) C4H8O2 
2.3 m/z 45 (MH+-C2H4O)
+              15% 
m/z 63 (MH+-C2H4O)
+ H2O
  
m/z 89 MH+                   85% 
m/z 107 MH+H2O 
1.8 m/z 87 (M-H)+              100% 
 
a Rate constants for the reactions of H3O+, NO+ and O2+• with ethylene glycol and 2-methyl-1,3-dioxolane 
(at 300K) are given in the units of 10−9 cm3 s−1. 
  
To summarize the gathered results, the H3O+ reaction of 2-methyl-1,3-dioxolane 
proceed via the following way: 
H3O+ + C4H8O2    → C4H9O2+ + H2O    (25a) 
→ C2H5O+ + C2H4O + H2O   (25b) 
Whilst the reaction mechanism is interesting, a detailed discussion is not warranted in this 
paper. Just to say that the reaction proceeds via exothermic proton transfer that results in 
partial dissociation of the nascent protonated methyl dioxolane. The rate coefficient for 
this reaction is calculated to be at the collisional limiting value, as given in Table 4.9. It 
is worthy of note that the protonated molecule at m/z 89 becomes partially hydrated as 
MH+H2O at m/z 107. This hydration process, well recognised and important in the 
analysis of many VOCs by SIFT-MS, is crucial to the understanding of acetaldehyde and 
ethylene glycol analyses (see below).  
The NO+ reaction is simple and proceeds thus: 
NO+ + C4H8O2    →  C4H7O2+ + HNO     (26) 
This reaction proceeds via hydride ion transfer, which is very typical of NO+ reactions at 
thermal energies (300K) at which these SIFT measurements were carried out [47, 313]. 
The rate coefficient is also close to the collisional value and is given in Table 4.9.  
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Using these kinetics data for either H3O+ or NO+ reagent ion, the concentration of 
the 2-methyl-1,3-dioxolane released into the nitrogen gas in the Nalophan bag can be 
determined (see later). 
The kinetics data for the reactions of H3O+ and NO+ with ethylene glycol have 
been determined previously [313,314], but present data are again summarised in Table 
4.9. Note that the product ions for the H3O+ reaction are unfortunately just the same as 
those for acetaldehyde reaction [315], thus it is important to discuss them side-by-side. 
The primary reactions of acetaldehyde with H3O+ proceed thus: 
H3O+ + C2H4O    →  C2H5O+ + H2O    (27) 
Whereas, the primary reactions of acetaldehyde with H3O+ proceed by the following 
channel: 
H3O+ + C2H6O2    →  C2H7O2 + + H2O    (28a) 
     →  C2H5O + + 2H2O    (28a) 
Thus, there is a common product ion at m/z 45 for these two reactions. Further to 
this complication, in the inevitable presence of water vapour, the latter ion hydrates 
producing C2H5O+(H2O)2 ions at m/z 63 and m/z 81, as shown in Table 4.9. This 
complicates the analysis of these VOCs when they are both present in a sample. 
Fortunately, in SIFT-MS, NO+ can be used to analyse a sample, as indicated below. 
The reaction of NO+ with acetaldehyde proceeds thus: 
NO+ + C2H4O     →  C2H3O+ + HNO    (29a) 
    + (He) →  NO+.C2H4O + (He)   (29b) 
Reaction (29a) is hydride ion transfer producing the closed shell ion C2H3O+ 
which does not undergo the secondary reactions of primary products with water [47, 313]. 
Reaction (29b) is a ternary association reaction mediated by carrier gas helium atoms 
(He) producing the adduct ion.  
The ethylene glycol reaction with NO+ proceeds thus: 
NO+ + C2H6O2    →  C2H5O2 + + HNO    (30a) 
    + (He) →  NO+.C2H6O2 + (He)   (30b) 
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The reaction processes are as for acetaldehyde, but different product ions are 
formed in these reaction. Thus, NO+ reactions can be used to distinguish between 
acetaldehyde and ethylene glycol and NO+ reagent ions can be used to quantify 
concentrations of these compounds by using SIFT-MS analytical method.  
 
Secondary electrospray ionisation mass spectrometry (SESI-MS)  
As can be seen from the Figure 4.18, nitrogen gas contained in the Nalophan bags 
is giving rather simple SESI-MS spectrum. The major ion peaks are the hydrated 
hydronium ions H3O+(H2O)1,2,3 at m/z 37, 55 and 73, which are always present in SESI 
mass spectra. At m/z 63, 81 and 99 we can see the ion peaks related to the protonated 
ethylene glycol (reaction 28a) and its hydrates, C2H7O2+(H2O)0,1,2. The peak at m/z 45 
corresponds to loss of H2O from C2H7O2+ (reaction 28b). 2-Methyl-1,3-dioxolane 
corresponds to protonated molecule at m/z 89 (reaction 25a). 
 
 
Figure 4.18. SESI-MS spectra of Nalophan bags at different temperatures and N2 background 
(analysed by continuously flushing dry nitrogen into the SESI source - labeled as “N2 background” to avoid 
the influence of any sampling bags or other materials).  
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Selected ion flow tube mass spectrometry (SIFT-MS) and time profiles (MIM) 
SIFT-MS quantification of both methyl dioxolane and ethylene glycol can be 
achieved using the ion-molecule reaction kinetics data given in Table 4.9.  
With the knowledge of the analyte ion m/z values for the methyl dioxolane and 
the ethylene glycol, the MIM mode of SIFT-MS can be used to record their concentrations 
in the Nalophan bags as a function of time. Thus, four Naplophan bags were constructed 
and each was fully expanded with dry cylinder nitrogen. A drop of liquid water was 
injected into two of the bags, which were then labelled as “dry” and “humid”. The 
nitrogen in one “dry” and one “humid” bag were analysed at 20˚C by SIFT-MS. This 
procedure was repeated for a “dry” bag and a “humid” bag placed in a thermostat held at 
37˚C (simulating exhaled breath). The concentrations, in parts-per-billion by volume, 
ppbv, in the bags immediately after inflation, 0 mins, and after times durations of 15, 30, 
45, 100 and 160 minutes at the two temperatures are shown by the vertical bar charts for 
ethylene glycol in Figure 4.19a and for the dioxolane in Figure 4.19b. These graphic data 
are essentially self-explanatory. It is seen that release of both compounds from the 
Nalophan is promoted by increased temperature and storage time.  
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Figure 4.19. Concentrations in ppbv a) ethylene glycol and b) 2-methyl-1,3-dioxolane released by 
Nalophan bags into dry and humid nitrogen at atmospheric pressure stored for different times at 
different temperatures.  
 
b
) 
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The influence of water vapour is only small but, perhaps, somewhat greater for 2-
methyl-1,3-dioxolane release. The increase in the concentrations of both compounds is 
not linear with time, but appears to asymptotically approach a steady concentration at 
which compound release ceases or the compounds in the headspace are in equilibrium 
with those in the Nalophan material. The approximate release of ethylene glycol from the 
25 μm Nalophan foil is about 10 pmol per cm2 and that for the methyl dioxolane is about 
1 pmol per cm2.  
 
Conclusions 
The release of contaminants from the sampling bag material is obviously of 
concern and the present work, focused on Nalophan bags commonly used for exhaled 
breath sample collection and analysis, has shown that two VOCs are released, resulting 
in gas phase concentrations of 20 to 250 ppbv for ethylene glycol and 2 to 35 ppbv for 2-
methyl-1,3-dioxolane, as measured in sample bags of typical diameter. These 
concentrations increased with storage time and temperature and to a lesser degree with 
the stored sample humidity. In addition to the above determined impurities connected 
with Nalophan bags, other compounds may be present at much lower concentration they 
are below the limit of detection of the current SIFT-MS instrumentation.  
The main issue connected with this topic is that metabolites in exhaled breath of 
clinical significance are often at sub-ppbv levels and bag material released impurities 
must not be wrongly interpreted as breath metabolites. The particular danger is connected 
to impurities that change with storage time and could thus lead to artefacts in multivariate 
statistical analyses of mass spectral data (as was also the case of breath samples obtained 
in cooperation with ISCARE, which were used in the pilot study focused on IBD 
biomarkers). 
In SIFT-MS breath analyses the following analyte ions are affected by Nalophan 
bag impurities: for H3O+ m/z 45, 63, 81, 89 and 99 and for NO+ m/z 61, 87 and 92. The 
compounds affected are thus acetaldehyde for H3O+ (noting that it can be analysed using 
NO+ at m/z 74), obviously ethylene glycol itself, any of the heptene isomers or hexanal 
(overlapping at m/z 99), many terpenes (fragment at m/z 81), acetoin (m/z 89), butyric 
acid (also m/z 89). Any of these compound producing analyte ions overlapping with 
Nalophan impurities should be analysed using NO+ when possible. The NO+ situation is 
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less severe with no notable overlaps with identified breath metabolites other than ethylene 
glycol itself. Review of the literature does not reveal any impact of these findings on 
previously published breath analyses results obtained using SIFT-MS, as breath 
acetaldehyde reported by [316] was measured from direct exhalations without using 
Nalophan bags and none of the metabolites listed above were reported in any previous 
Nalophan bag breath studies.
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5 Summary and concluding remarks       
This thesis summarises my research in the area of breath analysis for clinical 
diagnosis and selected ion flow tube mass spectrometry, SIFT-MS. It covers all the steps 
of my work, which were performed to achieve the aim of my PhD research project as 
formulated at the onset of my postgraduate study. Thus, variety of subjects was covered 
from the fundamental ion chemistry, via determination of new possible breath biomarkers 
in connection with inflammatory bowel disease, IBD, to characterisation of impurities 
presented in the Nalophan bags - the sampling material commonly used for exhaled breath 
sample collection and analysis.  
There are several outcomes of my work: 
 
1. The kinetic data for the ion-molecule reaction of group of carboxylic acids, IBD 
possible biomarkers and the compounds released from the Nalophan bags as 
impurities have been obtained. The rate constants and product ion branching ratios 
were published in peer reviewed journals for more than 50 reactions (Appendices 
A, B, C and D).  
2. The secondary association reactions of primary product ions with water molecules 
have been investigated and the relevant kinetic data obtained. The understanding 
of these reactions is necessary for comprehensive and full understanding of the 
ion chemistry, to be used for accurate quantification by SIFT-MS (Appendices A, 
B). 
3. The methodology for optimization of kinetics library entries avoiding cross 
sensitivity was formulated for compounds of interest and in detail described 
(Appendices A, C). 
4. Selected VOCs have been investigated in order to confirm their significance as 
IBD possible biomarkers. SIFT-MS has been confirmed as a technique capable to 
conduct analysis of IBD possible biomarkers, including alkenes, in breath (when 
they are really present in the sample), but only under certain conditions (on-line 
analysis/defined storage time of breath samples in Nalophan bags, choice of 
suitable reagent ions). The reason is the possible cross sensitivity with the 
compounds released by Nalophan bag (ethylene glycol) (so far not published).  
5. The mean concentrations of alkenes in the breath of healthy people were 
determined (usually below 10 ppbv). The comparison of results obtained for 
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healthy volunteer and IBD suffering patient confirmed the hypothesis, that 
presence of heptene in the breath of IBD suffering patient is higher (so far not 
published).   
6. We have investigated in detail the release of contaminants from the Nalophan 
bags, whereas two VOCs released in concentrations detectable by SIFT-MS have 
been confirmed in sample bags of typical diameter, namely ethylene glycol  (gas 
phase concentrations of 20 to 250 ppbv) and 2-methyl-1,3-dioxolane (2 to 35 
ppbv). It was also confirmed, that concentrations of these compounds increase 
depending on storage time, temperature and to a lesser degree on sample humidity. 
This study has again indicated, that qualitative GC-MS analysis is important in 
order to facilitate reliable SIFT-MS targeted quantification. The following analyte 
ions were identified as those affected by Nalophan bag impurities: for H3O+ m/z 
45, 63, 81, 89 and 99 (thus acetaldehyde, ethylene glycol itself, heptene isomers, 
hexanal, many terpenes, acetoin and butyric acid) and for NO+ m/z 61, 87 and 92. 
The solution could be analysis by using of NO+ reagent ions. (Appendix D). 
 
I really hope, that the above mentioned results will be useful for other researchers 
working in areas of science related to breath analyses and SIFT-MS and will facilitate 
further progress and developments.  
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